10X Genomics, Inc. v. Curio Bioscience, Inc.
1:23-cv-01375
Overview
Case Number
1:23-cv-01375
Filing Date
2023-12-01
Status
Litigation filed
Court
District Court, D. Delaware
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. Delaware
Presiding Judge
Maryellen Noreika
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
1
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against Curio Bioscience, Inc. ( Filing fee $ 405, receipt number BDEDC-4285295.) - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Civil Cover Sheet)(apk) (Entered: 12/04/2023)
2023-12-01
2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) (Entered: 12/04/2023)
2023-12-01
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,480,022 ;10,662,468 ;11,001,879 ;11,549,138 ;11,761,030. (apk) (Entered: 12/04/2023)
2023-12-01
1
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by 10X Genomics, Inc. (apk) (Entered: 12/04/2023)
2023-12-01
1
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Prognosys Biosciences, Inc. (apk) (Entered: 12/04/2023)
2023-12-01
1
Summons Issued as to Curio Bioscience, Inc. on 12/1/2023. (apk) (Entered: 12/04/2023)
2023-12-01
1
Return of Service Executed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. Curio Bioscience, Inc. served on 12/5/2012, answer due 12/26/2012. (Ewing, Alexandra) (Entered: 12/05/2023)
2023-12-05
1
Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb)
2023-12-06
1
No Actions
Case Assigned/Reassigned
2023-12-06
1
No Actions
STIPULATION TO EXTEND TIME for Defendant Curio Bioscience Inc. to answer, move, or otherwise respond to the Complaint to 2/1/2024 - filed by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 12/21/2023)
2023-12-21
1
SO ORDERED
2023-12-21
1
No Actions
SO ORDERED AND ~Util - Set/Reset Answer Deadline
2023-12-21
1
No Actions
SO ORDERED re 8 STIPULATION TO EXTEND TIME for Defendant Curio Bioscience Inc. to answer, move, or otherwise respond to the Complaint to 2/1/2024 (Set/Reset Answer Deadlines: Curio Bioscience, Inc. answer due 2/1/2024). ORDERED by Judge Maryellen Noreika on 12/21/2023. (dlw)
2023-12-21
1
No Actions
Pro Hac Vice Fee - Credit Card Payment received for Matthew Powers, Paul Ehrlich, Stefani Smith, Robert Gerrity, and Li Shen. ( Payment of $ 250, receipt number ADEDC-4325623).(Ewing, Alexandra) (Entered: 01/30/2024)
2024-01-30
1
Pro Hac Vice Fee - Credit Card Payment received for Ronald J. Pabis, Kiley White, and Joanna R. Schacter. ( Payment of $ 150, receipt number ADEDC-4325639).(Ewing, Alexandra) (Entered: 01/30/2024)
2024-01-30
1
MOTION for Pro Hac Vice Appearance of Attorney Matthew Powers, Paul Ehrlich, Stefani Smith, Robert Gerrity, Li Shen, Ronald J. Pabis, Kiley White, Joanna R. Schacter - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Certification - Powers, # 2 Certification - Ehrlich, # 3 Certification - Smith, # 4 Certification - Gerrity, # 5 Certification - Pabis, # 6 Certification - White, # 7 Certification - Schacter, # 8 Certification - Shen)(Ewing, Alexandra) (Entered: 01/30/2024)
2024-01-30
1
-District Court Pro Hac Vice Fee - 05 Attorneys Credit Card Payment
2024-01-30
1
No Actions
-District Court Pro Hac Vice Fee - 03 Attorneys Credit Card Payment
2024-01-30
1
No Actions
SO ORDERED
2024-01-30
1
No Actions
SO ORDERED re 11 MOTION for Pro Hac Vice Appearance of Attorney Matthew Powers, Paul Ehrlich, Stefani Smith, Robert Gerrity, Li Shen, Ronald J. Pabis, Kiley White, Joanna R. Schacter filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. ORDERED by Judge Maryellen Noreika on 1/30/2024. (dlw)
2024-01-30
1
No Actions
MOTION to Dismiss for Failure to State a Claim - filed by Curio Bioscience, Inc.. (Farnan, Michael) (Entered: 02/01/2024)
2024-02-01
1
OPENING BRIEF in Support re 12 MOTION to Dismiss for Failure to State a Claim filed by Curio Bioscience, Inc..Answering Brief/Response due date per Local Rules is 2/15/2024. (Farnan, Michael) (Entered: 02/01/2024)
2024-02-01
1
DECLARATION of Abigail L. Sellers re 13 Opening Brief in Support by Curio Bioscience, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Farnan, Michael) Modified on 2/2/2024 (dlw). (Entered: 02/01/2024)
2024-02-01
1
Add Attorneys - PHV only
2024-02-01
1
No Actions
Add Attorneys Pro Hac Vice
2024-02-01
1
No Actions
Pro Hac Vice Attorneys Paul T. Ehrlich, Robert L. Gerrity, Ronald J. Pabis, Matthew D. Powers, Joanna Schacter, Li Shen, Stefani C. Smith, and Kiley White for 10X Genomics, Inc. and Prognosys Biosciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
2024-02-01
1
No Actions
ORAL ORDER - IT IS HEREBY ORDERED that, within thirty (30) days from the date of this Order, the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, which is also consistent with the following guidance. The parties shall provide final contentions (i.e., final infringement and invalidity contentions, as well as final non-infringement and validity contentions) around the time that fact discovery closes (i.e., several weeks prior to or after the deadline to complete fact discovery) and at least three weeks before Plaintiffs serve their opening claim construction brief. Final contentions shall include a party's contentions under its proposed construction(s), as well as under the opposing construction(s) (if such an alternative contention exists). As such, the parties are encouraged to exchange proposed claim terms and proposed constructions early in the case but in no event later than necessary to allow the parties to include alternative contentions in their final contentions. The joint claim construction chart shall be due one week after the parties have completed their exchange of final contentions, and the joint claim construction brief must be filed at least three weeks before the claim construction hearing. The parties shall leave at least three weeks between the claim construction hearing and the opening of expert discovery. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms), and the parties must include a proposal for the length and timing of trial. If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 2/2/2024. (dlw) (Entered: 02/02/2024)
2024-02-02
1
Oral Order
2024-02-02
1
No Actions
ANSWERING BRIEF in Opposition re 12 MOTION to Dismiss for Failure to State a Claim filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..Reply Brief due date per Local Rules is 2/22/2024. (Rawnsley, Jason) (Entered: 02/15/2024)
2024-02-15
1
DECLARATION of Robert Gerrity re 16 Answering Brief in Opposition by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit 13)(Rawnsley, Jason) Modified on 2/15/2024 (dlw). (Entered: 02/15/2024)
2024-02-15
1
REPLY BRIEF re 12 MOTION to Dismiss for Failure to State a Claim filed by Curio Bioscience, Inc.. (Farnan, Michael) (Entered: 02/22/2024)
2024-02-22
1
REQUEST for Oral Argument by 10X Genomics, Inc., Prognosys Biosciences, Inc. re 12 MOTION to Dismiss for Failure to State a Claim . (Ewing, Alexandra) (Entered: 02/27/2024)
2024-02-27
1
Letter to The Honorable Maryellen Noreika from Frederick L. Cottrell, III regarding Proposed Case Schedule. (Attachments: # 1 Exhibit A)(Cottrell, Frederick) (Entered: 03/04/2024)
2024-03-04
1
ORAL ORDER Setting Scheduling Conference - IT IS HEREBY ORDERED that a Scheduling Conference is set for 3/13/2024 at 02:00 PM in Courtroom 4A before Judge Maryellen Noreika. ORDERED by Judge Maryellen Noreika on 3/5/2024. (dlw) (Entered: 03/05/2024)
2024-03-05
1
Order Setting Scheduling Conference
2024-03-05
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Morgan Chu, Alan Heinrich, Andrew Krause, and Abigail Sellers - filed by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 03/11/2024)
2024-03-11
1
Pro Hac Vice Fee - Credit Card Payment received for Morgan Chu, Alan Heinrich, Andrew Krause, and Abigail Sellers. ( re 22 MOTION for Pro Hac Vice Appearance of Attorney Morgan Chu, Alan Heinrich, Andrew Krause, and Abigail Sellers )( Payment of $ 200, receipt number ADEDC-4358130).(Farnan, Brian) (Entered: 03/11/2024)
2024-03-11
1
SO ORDERED
2024-03-11
1
No Actions
-District Court Pro Hac Vice Fee - 04 Attorneys Credit Card Payment
2024-03-11
1
No Actions
SO ORDERED re 22 MOTION for Pro Hac Vice Appearance of Attorney Morgan Chu, Alan Heinrich, Andrew Krause, and Abigail Sellers filed by Curio Bioscience, Inc. ORDERED by Judge Maryellen Noreika on 3/11/2024. (dlw)
2024-03-11
1
No Actions
Scheduling Conference
2024-03-13
1
No Actions
Minute Entry for proceedings held before Judge Maryellen Noreika - Scheduling Conference held on 3/13/2024 in Courtroom 4A re Proposed Schedule ( 20 ). A jury trial is set to begin on May 18, 2026. The parties shall confer on the remaining dates of the schedule and submit a revised version within two weeks. (Court Reporter Dale Hawkins.) (mdb)
2024-03-13
1
No Actions
Letter to The Honorable Maryellen Noreika from Frederick L. Cottrell, III regarding Proposed Scheduling Order. (Attachments: # 1 Proposed Scheduling Order)(Cottrell, Frederick) (Entered: 03/27/2024)
2024-03-27
1
Add Attorneys Pro Hac Vice
2024-03-28
1
No Actions
Add Attorneys - PHV only
2024-03-28
1
No Actions
Pro Hac Vice Attorney Andrew Krause for Curio Bioscience, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam)
2024-03-28
1
No Actions
SCHEDULING ORDER: Joinder of Parties due by 9/23/2024. Amended Pleadings due by 9/23/2024. Fact Discovery completed by 4/16/2025. Opening Expert Reports due by 8/29/2025. Rebuttal Expert Reports due by 9/26/2025. Reply Expert Reports due by 10/17/2025. Expert Discovery due by 10/31/2025. Dispositive Motions due by 11/21/2025. Answering Brief due 12/19/2025. Reply Brief due 1/9/2026. Claim Construction Opening Brief served by 4/30/2021. Claim Construction Answering Brief served by 5/21/2025. Claim Construction Reply Brief served by 6/6/2025. Claim Construction Surreply Brief served by 6/18/2025. Joint Claim Construction Brief filed by 6/25/2025. A Markman Hearing is set for 7/16/2025 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 5/11/2026 at 04:30 PM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Jury Trial is set for 5/18/2026 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 4/1/2024. (dlw) Modified on 4/3/2024 (dlw). (Entered: 04/01/2024)
2024-04-01
1
NOTICE OF SERVICE of Plaintiffs' Amended Disclosure Pursuant to Paragraph 4 of the Delaware Default Standard for Discovery filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Ewing, Alexandra) (Entered: 04/01/2024)
2024-04-01
1
NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Plaintiffs Disclosure Pursuant to Paragraph 3 of the Delaware Default Standard of Discovery filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Ewing, Alexandra) (Entered: 04/11/2024)
2024-04-11
1
NOTICE OF SERVICE of Defendant's Initial Disclosure Pursuant to the Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 04/11/2024)
2024-04-11
1
NOTICE OF SERVICE of Defendant's First Set of Interrogatories to Plaintiffs 10X Genomics, Inc. and Prognosys Biosciences Inc. filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 04/26/2024)
2024-04-26
1
STIPULATION TO EXTEND TIME and [Proposed] Order for (1) parties to submit a proposed form of order to govern E-Discovery and (2) apply to the Court for a Protective Order to May 8, 2024 - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 05/01/2024)
2024-05-01
1
SO ORDERED
2024-05-01
1
No Actions
SO ORDERED re 30 STIPULATION and Order to Extend Time for the parties to: (1) submit a proposed form of order to govern E-Discovery and (2) apply for a Protective Order to May 8, 2024. ORDERED by Judge Maryellen Noreika on 5/1/2024. (dlw)
2024-05-01
1
No Actions
NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Curio Bioscience, Inc. (Nos. 1-4) and Plaintiffs' First Set of Requests for Production to Curio Bioscience, Inc. (Nos. 1-54) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Rawnsley, Jason) (Entered: 05/03/2024)
2024-05-03
1
PROPOSED ORDER [DISPUTED] Regarding Discovery, Including Electronically Stored Information ("ESI") by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 05/08/2024)
2024-05-08
1
PROPOSED ORDER - STIPULATED Protective Order by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 05/08/2024)
2024-05-08
1
ORAL ORDER DENYING 12 Motion to Dismiss - Defendant has filed a motion to dismiss for failure to state a claim, arguing that five claims across the five patents identified in the Complaint are directed to ineligible subject matter under 35 U.S.C. § 101. The Court is concerned that more claims will ultimately be asserted in this case beyond the five identified in the Complaint. Indeed, although Plaintiff has yet to provide its infringement contentions, the Scheduling Order in this case references assertion of up to 50 claims across the patents (to be later dropped to 20 claims). Given that Defendant's § 101 motion may require the Court to address claims that may not ultimately be asserted and appears to require the Court to address eligibility multiple times, IT IS HEREBY ORDERED that Defendant's motion to dismiss is DENIED. ORDERED by Judge Maryellen Noreika on 5/9/2024. (dlw) (Entered: 05/09/2024)
2024-05-09
1
Order on Motion to Dismiss/Fail to State Claim
2024-05-09
1
No Actions
STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 5/10/2024. (dlw) (Entered: 05/10/2024)
2024-05-10
1
NOTICE OF SERVICE of Defendant's First Amended Initial Disclosure Pursuant to the Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Curio Bioscience, Inc..(Farnan, Michael) (Entered: 05/10/2024)
2024-05-10
1
NOTICE OF SERVICE of Plaintiffs' Amended Disclosure Pursuant to Paragraph 3 of the Disputed Proposed Discovery Order filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Ewing, Alexandra) (Entered: 05/10/2024)
2024-05-10
1
STIPULATION TO EXTEND TIME for Defendant Curio Bioscience Inc. to answer the Complaint to 5/31/2024 - filed by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 05/15/2024)
2024-05-15
1
ORAL ORDER re 32 [Proposed] [Disputed] Order Regarding Discovery, including Electronically Stored Information ("ESI") - Having reviewed the parties' competing proposals for Paragraph 5, IT IS HEREBY ORDERED that Plaintiffs' Proposal is ADOPTED except that before any dispute is raised with the Court all meet and confer requirements must be met. On or before 5/17/2024, the parties shall submit a revised Proposed ESI Order. ORDERED by Judge Maryellen Noreika on 5/15/2024. (dlw) (Entered: 05/15/2024)
2024-05-15
1
SO ORDERED re 38 STIPULATION TO EXTEND TIME for Defendant Curio Bioscience Inc. to answer the Complaint to 5/31/2024 (Set/Reset Answer Deadlines: Curio Bioscience, Inc. answer due 5/31/2024). ORDERED by Judge Maryellen Noreika on 5/15/2024. (dlw)
2024-05-15
1
No Actions
SO ORDERED AND ~Util - Set/Reset Answer Deadline
2024-05-15
1
No Actions
Oral Order
2024-05-15
1
No Actions
STIPULATION [Proposed] and Order Regarding Discovery, Including Electronically Stored Information ("ESI") by 10X Genomics, Inc.. (Rawnsley, Jason) (Entered: 05/17/2024)
2024-05-17
1
STIPULATION AND ORDER REGARDING DISCOVERY, INCLUDING ELECTRONICALLY STORED INFORMATION ("ESI"). Signed by Judge Maryellen Noreika on 5/17/2024. (dlw) (Entered: 05/17/2024)
2024-05-17
1
NOTICE OF SERVICE of (i) Defendant's Second Set of Interrogatories to Plaintiffs 10X Genomics, Inc. and Prognosys Biosciences Inc. (Nos. 2-4) and (ii) Defendant's First Set of Requests for Production to Plaintiffs 10X Genomics, Inc. and Prognosys Biosciences Inc. (Nos. 1-29) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/22/2024)
2024-05-22
1
NOTICE OF SERVICE of Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences, Inc.s Objections and Responses to Curio Bioscience, Inc.s First Set of Interrogatories (No. 1) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Ewing, Alexandra) (Entered: 05/28/2024)
2024-05-28
1
MOTION for Pro Hac Vice Appearance of Attorney Kevin B. Collins, Andrew D. Lazerow, Matthew Kudzin, and Paul Enriquez - filed by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 05/29/2024)
2024-05-29
1
Pro Hac Vice Fee - Credit Card Payment received for Kevin B. Collins, Andrew D. Lazerow, Matthew Kudzin, and Paul Enriquez. ( re 44 MOTION for Pro Hac Vice Appearance of Attorney Kevin B. Collins, Andrew D. Lazerow, Matthew Kudzin, and Paul Enriquez )( Payment of $ 200, receipt number ADEDC-4417368).(Farnan, Brian) (Entered: 05/29/2024)
2024-05-29
1
-District Court Pro Hac Vice Fee - 04 Attorneys Credit Card Payment
2024-05-29
1
No Actions
SO ORDERED
2024-05-29
1
No Actions
SO ORDERED re 44 MOTION for Pro Hac Vice Appearance of Attorney Kevin B. Collins, Andrew D. Lazerow, Matthew Kudzin, and Paul Enriquez filed by Curio Bioscience, Inc. ORDERED by Judge Maryellen Noreika on 5/29/2024. (dlw)
2024-05-29
1
No Actions
Add Attorneys - PHV only
2024-05-30
1
No Actions
Pro Hac Vice Attorneys Matthew Kudzin, Paul Enriquez, and Kevin B. Collins for Curio Bioscience, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)
2024-05-30
1
No Actions
Pro Hac Vice Attorney Andrew D. Lazerow for Curio Bioscience, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d). Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (vfm)
2024-05-30
1
No Actions
ANSWER to 1 Complaint,, with Jury Demand, COUNTERCLAIM against 10X Genomics, Inc., Prognosys Biosciences, Inc. by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/31/2024)
2024-05-31
1
NOTICE OF SERVICE of (i) Defendant's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-4) and (ii) Curio's Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1-54) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/03/2024)
2024-06-03
1
NOTICE OF SERVICE of Plaintiffs Initial Infringement Contentions filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Rawnsley, Jason) (Entered: 06/07/2024)
2024-06-07
1
ANSWER to 1 Complaint,, with Jury Demand, Amended COUNTERCLAIM against 10X Genomics, Inc., Prognosys Biosciences, Inc. by Curio Bioscience, Inc..(Farnan, Brian) (Additional attachment(s) added on 6/21/2024: # 1 Redline Comparison) (dlw). (Entered: 06/20/2024)
2024-06-20
1
NOTICE OF SERVICE of (1) Objections and Responses to First Set of Requests for Production (Nos. 1-29) and (2) Objections and Responses to Second Set of Interrogatories (Nos. 2-4) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Ewing, Alexandra) (Entered: 06/28/2024)
2024-06-28
1
MOTION to Dismiss Curio Bioscience, Inc.s First Through Fourth Counterclaims re 49 Answer to Complaint,, Counterclaim, - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Text of Proposed Order)(Rawnsley, Jason) (Entered: 07/05/2024)
2024-07-05
1
OPENING BRIEF in Support re 51 MOTION to Dismiss Curio Bioscience, Inc.s First Through Fourth Counterclaims re 49 Answer to Complaint,, Counterclaim, filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..Answering Brief/Response due date per Local Rules is 7/19/2024. (Rawnsley, Jason) (Entered: 07/05/2024)
2024-07-05
1
[SEALED] DECLARATION of Li Shen re 51 MOTION to Dismiss Curio Bioscience, Inc.s First Through Fourth Counterclaims re 49 Answer to Complaint,, Counterclaim by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit 1-6)(Rawnsley, Jason) Modified on 7/8/2024 (dlw). (Entered: 07/05/2024)
2024-07-05
1
STIPULATION TO EXTEND TIME for Defendant Curio Bioscience, Inc. to serve its Initial Invalidity Contentions to 7/16/2024 - filed by Curio Bioscience, Inc.. (Farnan, Michael) (Entered: 07/08/2024)
2024-07-08
1
SO ORDERED
2024-07-08
1
No Actions
SO ORDERED re 54 STIPULATION TO EXTEND TIME for Defendant Curio Bioscience, Inc. to serve its Initial Invalidity Contentions to 7/16/2024. ORDERED by Judge Maryellen Noreika on 7/8/2024. (dlw)
2024-07-08
1
No Actions
NOTICE OF SERVICE of (1) Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences, Inc.s First Supplemental Objections and Responses to Curio Bioscience, Inc.s First Set Interrogatories (No. 1) and (2) Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences, Inc.s First Amended Objections and Responses to Curio Bioscience, Inc.s Second Set of Interrogatories (Nos. 2-4) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Rawnsley, Jason) (Entered: 07/10/2024)
2024-07-10
1
STIPULATION TO EXTEND TIME (i) for Defendant to Respond to Plaintiffs' Motion to Dismiss and (ii) for Plaintiffs to submit their Reply to Defendant's Response to (i) 8/2/2024 and (ii) 8/23/2024 - filed by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 07/11/2024)
2024-07-11
1
REDACTED VERSION of 53 Declaration by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit 1-6)(Rawnsley, Jason) Modified on 7/12/2024 (dlw). (Entered: 07/12/2024)
2024-07-12
1
SO ORDERED AND ~Util - Set Briefing Schedule - open,ans,reply,surreply
2024-07-12
1
No Actions
SO ORDERED re 56 STIPULATION TO EXTEND TIME (i) for Defendant to Respond to Plaintiffs' Motion to Dismiss and (ii) for Plaintiffs to submit their Reply to Defendant's Response to (i) 8/2/2024 and (ii) 8/23/2024 (Set Briefing Schedule: re 51 MOTION to Dismiss Curio Bioscience, Inc.s First Through Fourth Counterclaims - Answering Brief due 8/2/2024. Reply Brief due 8/23/2024). ORDERED by Judge Maryellen Noreika on 7/12/2024. (dlw)
2024-07-12
1
No Actions
NOTICE OF SERVICE of (i) Defendant's Third Set of Interrogatories to Plaintiffs 10X Genomics, Inc. and Prognosys Biosciences Inc. (No. 5) and (ii) Defendant Curio Bioscience, Inc.'s Initial Invalidity Contentions filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 07/17/2024)
2024-07-17
1
NOTICE OF SERVICE of Defendant's First Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-2) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 07/22/2024)
2024-07-22
1
NOTICE OF SERVICE of Defendant Curio Bioscience, Inc.'s Initial Disclosure of Proposed Terms for Construction filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 07/24/2024)
2024-07-24
1
NOTICE of Appearance by Gabriela Monasterio on behalf of 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) (Entered: 07/25/2024)
2024-07-25
1
ANSWERING BRIEF in Opposition re 51 MOTION to Dismiss Curio Bioscience, Inc.s First Through Fourth Counterclaims re 49 Answer to Complaint,, Counterclaim filed by Curio Bioscience, Inc. Reply Brief due date per 56 Stipulation and Order is 8/23/2024. (Farnan, Brian) Modified on 8/5/2024 (dlw). (Entered: 08/02/2024)
2024-08-02
1
NOTICE OF SERVICE of Defendant's Second Set of Requests for Production to Plaintiffs 10X Genomics, Inc. and Prognosys Biosciences Inc. (Nos. 30-45) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 08/02/2024)
2024-08-02
1
REPLY BRIEF re 51 MOTION to Dismiss Curio Bioscience, Inc.s First Through Fourth Counterclaims re 49 Answer to Complaint,, Counterclaim, filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 08/23/2024)
2024-08-23
1
ORAL ORDER re 51 MOTION to Dismiss First Through Fourth Counterclaims - The Court intends to refer the pending motion to a magistrate judge and requests that the parties consider consenting to the magistrate judge's jurisdiction over the motion. THEREFORE, IT IS HEREBY ORDERED that, on or before August 30, 2024, the parties shall inform the Court whether they consent to a magistrate's jurisdiction over the pending motion. If the parties consent, they should complete the attached form and email it to diana_welham@ded.uscourts.gov. In addressing the Court, the parties should in no way inform the Court which, if any, party or parties declined to consent. ORDERED by Judge Maryellen Noreika on 8/29/2024. (dlw) (Entered: 08/29/2024)
2024-08-29
1
Joint Letter to The Honorable Maryellen Noreika from Frederick L. Cottrell, III regarding Consent to Magistrate - re 65 Order,, 51 MOTION to Dismiss Curio Bioscience, Inc.s First Through Fourth Counterclaims re 49 Answer to Complaint,, Counterclaim, . (Cottrell, Frederick) (Entered: 08/30/2024)
2024-08-30
1
NOTICE OF SERVICE of Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences, Inc.s Objections and Responses to Curio Bioscience, Inc.s Third Set of Interrogatories (No. 5) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 08/30/2024)
2024-08-30
1
NOTICE OF SERVICE of Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences, Inc.'s Objections and Responses to Defendant Curio Bioscience, Inc.'s Second Set of Requests for Production (Nos. 30-45) by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Ewing, Alexandra) Modified on 9/3/2024 (dlw). (Entered: 09/03/2024)
2024-09-03
1
ORAL ORDER REFERRING 51 MOTION to Dismiss Curio Bioscience, Inc.s First Through Fourth Counterclaims - IT IS HEREBY ORDERED that this motion is referred to Magistrate Judge Christopher J. Burke. ORDERED by Judge Maryellen Noreika on 9/5/2024. Motions referred to Christopher J. Burke.(dlw) (Entered: 09/05/2024)
2024-09-05
1
Remark: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (smg)
2024-09-05
1
No Actions
Order Referring Motion
2024-09-05
1
No Actions
Remark (CJB Courtesy Copy Requirement)
2024-09-05
1
No Actions
Remark re Newer Attorneys
2024-09-05
1
No Actions
Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf (smg)
2024-09-05
1
No Actions
REPORT AND RECOMMENDATIONS re D.I. 51 MOTION to Dismiss Curio Bioscience, Inc.s First Through Fourth Counterclaims re 49 Answer to Complaint,, Counterclaim, filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 2/12/2025. Signed by Judge Christopher J. Burke on 01/29/2025. (smg) (Entered: 01/29/2025)
2025-01-29
1
NOTICE OF SERVICE of Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences, Inc.s Supplemental Identification of Accused Products filed by 10X Genomics, Inc..(Monasterio, Gabriela) (Entered: 01/29/2025)
2025-01-29
1
NOTICE OF SERVICE of (i) Defendant's Third Set of Requests for Production to Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences Inc. and (ii) Defendant's Fourth Set of Interrogatories to Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences Inc. filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 02/14/2025)
2025-02-14
1
ORDER ADOPTING 70 REPORT AND RECOMMENDATION GRANTING-IN-PART and DENYING-IN-PART 51 Plaintiffs 10X Genomics, Inc. and Prognosys Biosciences, Inc.'s Motion to Dismiss Curio Biosciences, Inc.'s First through Fourth Counterclaims. The motion is GRANTED without prejudice as to the First and Third Counterclaims and DENIED as to the Second Counterclaim. As for the Fourth Counterclaim, the motion is GRANTED without prejudice as to those portions of the counterclaim premised upon the grounds for relief stated in the First and Third Counterclaims and DENIED as to the portions of the counterclaim premised upon the grounds for relief stated in the Second Counterclaim. IT IS FURTHER ORDERED that the Report's recommendation regarding the bifurcation and stay request is ADOPTED. (See D.I. 70 at 23-24). Signed by Judge Maryellen Noreika on 2/21/2025. (dlw) (Entered: 02/21/2025)
2025-02-21
1
NOTICE of Subpoena Directed to Takara Bio USA, Inc. by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit Subpoena)(Ewing, Alexandra) (Entered: 03/07/2025)
2025-03-07
1
ANSWER to 49 Answer to Complaint, Counterclaim // Plaintiff's Answer and Affirmative Defenses to Defendant Curio Bioscience, Inc.'s First Amended Counterclaims by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Ewing, Alexandra) Modified on 3/7/2025 (dlw). (Entered: 03/07/2025)
2025-03-07
1
STIPULATION TO EXTEND TIME to Extend Deadlines and Modify Case Schedule and [Proposed] Order - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 03/14/2025)
2025-03-14
1
SO ORDERED re 76 STIPULATION and Order to Extend Deadlines and Modify Case Schedule (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 6/13/2025). Signed by Judge Maryellen Noreika on 3/14/2025. SEE STIPULATION FOR FURTHER AND COMPLETE DETAILS. (dlw) (Entered: 03/14/2025)
2025-03-14
1
MOTION for Pro Hac Vice Appearance of Attorney Grace Gretes and Parshad K. Brahmbhatt - filed by 10X Genomics, Inc.. (Monasterio, Gabriela) (Entered: 03/17/2025)
2025-03-17
1
Pro Hac Vice Fee - Credit Card Payment received for Grace Gretes and Parshad K. Brahmbhatt. ( re 78 MOTION for Pro Hac Vice Appearance of Attorney Grace Gretes and Parshad K. Brahmbhatt )( Payment of $ 100, receipt number ADEDC-4638433).(Monasterio, Gabriela) (Entered: 03/17/2025)
2025-03-17
1
SO ORDERED re 78 MOTION for Pro Hac Vice Appearance of Attorney Grace Gretes and Parshad K. Brahmbhatt filed by 10X Genomics, Inc. ORDERED by Judge Maryellen Noreika on 3/17/2025. (dlw)
2025-03-17
1
No Actions
Pro Hac Vice Attorney Grace Gretes, Parshad K. Brahmbhatt for 10X Genomics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)
2025-03-17
1
No Actions
Add Attorneys - PHV only
2025-03-17
1
No Actions
-District Court Pro Hac Vice Fee - 02 Attorneys Credit Card Payment
2025-03-17
1
No Actions
SO ORDERED
2025-03-17
1
No Actions
NOTICE OF SERVICE of Plaintiffs Objections and Responses to Defendant's Third Set of Requests for Production (Nos. 46-59) and Objections and Responses to Fourth Set of Interrogatories (Nos.6-9) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 03/18/2025)
2025-03-18
1
NOTICE of Subpoenas by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Monasterio, Gabriela) (Entered: 03/18/2025)
2025-03-18
1
Joint STATUS REPORT by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 03/21/2025)
2025-03-21
1
MOTION to Bifurcate and Stay Curio's Antitrust Counterclaims - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Text of Proposed Order)(Rawnsley, Jason) Modified on 3/24/2025 (dlw). (Entered: 03/21/2025)
2025-03-21
1
MOTION to Bifurcate and Stay Curio's Antitrust Counterclaims - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Text of Proposed Order)(Rawnsley, Jason) Modified on 3/24/2025 (dlw). (Entered: 03/21/2025)
2025-03-21
2
OPENING BRIEF in Support re 83 MOTION to Bifurcate and Stay Curio's Antitrust Counterclaims filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. Answering Brief/Response due date per Local Rules is 4/4/2025. (Monasterio, Gabriela) Modified on 3/24/2025 (dlw). (Entered: 03/21/2025)
2025-03-21
1
DECLARATION of Li Shen re 84 Opening Brief in Support, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1 through 4)(Rawnsley, Jason) (Entered: 03/21/2025)
2025-03-21
1
CORRECTING ENTRY: D.I. 83 has been deleted from the docket at the request of counsel. (dlw)
2025-03-21
1
No Actions
- CORRECTING ENTRY
2025-03-21
1
No Actions
STIPULATION TO EXTEND TIME to Respond to Motion to Bifurcate and Stay Curio's Antitrust Counterclaims to April 8, 2025 - filed by Curio Bioscience, Inc.. (Farnan, Michael) (Entered: 03/27/2025)
2025-03-27
1
SO ORDERED AND ~Util - Set Briefing Schedule - open,ans,reply,surreply
2025-03-28
1
No Actions
SO ORDERED re 86 STIPULATION TO EXTEND TIME to Respond to Motion to Bifurcate and Stay Curio's Antitrust Counterclaims to April 8, 2025 (Set Briefing Schedule: re 83 MOTION to Bifurcate and Stay Curio's Antitrust Counterclaims - Answering Brief due 4/8/2025). ORDERED by Judge Maryellen Noreika on 3/28/2025. (dlw)
2025-03-28
1
No Actions
STIPULATION TO EXTEND Deadlines and Modify Schedule - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Ewing, Alexandra) Modified on 4/2/2025 (dlw). (Entered: 04/01/2025)
2025-04-01
1
SO ORDERED re 87 STIPULATION TO EXTEND Deadlines and Modify Schedule (Set/Reset Scheduling Order Deadlines - Claim Construction Opening Brief served by 6/11/2025. Claim Construction Answering Brief served by 7/2/2025. Claim Construction Reply Brief served by 7/18/2025. Claim Construction Surreply Brief served by 8/1/2025. Joint Claim Construction Brief filed by 8/6/2025. A Markman Hearing is set for 8/27/2025 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. Opening Expert Reports due by 9/26/2025. Rebuttal Expert Reports due by 10/24/2025. Reply Expert Reports due by 11/14/2025. Expert Discovery due by 11/25/2025. Dispositive Motions due by 12/9/2025. Answering Brief due 12/30/2025. Reply Brief due 1/13/2026). Signed by Judge Maryellen Noreika on 4/2/2025. (dlw) (Entered: 04/02/2025)
2025-04-02
1
ANSWERING BRIEF in Opposition re 83 MOTION to Bifurcate and Stay Curio's Antitrust Counterclaims filed by Curio Bioscience, Inc..Reply Brief due date per Local Rules is 4/15/2025. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 04/08/2025)
2025-04-08
1
NOTICE OF SERVICE of April 11, 2025 Infringement Contentions filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 04/11/2025)
2025-04-11
1
NOTICE OF SERVICE of (i) Defendant Curio Bioscience, Inc.'s Objections and Responses to Plaintiffs' Second Set of Requests for Production to Curio Bioscience, Inc. (Nos. 55-128) and (ii) Defendant Curio Bioscience, Inc.'s Final Invalidity Contentions filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 04/14/2025)
2025-04-14
1
REPLY BRIEF re 83 MOTION to Bifurcate and Stay Curio's Antitrust Counterclaims filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 04/15/2025)
2025-04-15
1
DECLARATION of Li Shen re 92 Reply Brief by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 5 to 7)(Rawnsley, Jason) (Entered: 04/15/2025)
2025-04-15
1
STIPULATION To Extend Deadlines and Modify Case Schedule by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Monasterio, Gabriela) (Entered: 04/23/2025)
2025-04-23
1
NOTICE OF SERVICE of Plaintiffs First Supplemental Objections and Responses to Defendants Second Set of Interrogatories (Nos. 2-4) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 04/23/2025)
2025-04-23
1
SO ORDERED re 94 Stipulation and Order to Extend Deadlines and Modify Case Schedule (final contentions and joint claim chart). Signed by Judge Maryellen Noreika on 4/24/2025. (dlw) (Entered: 04/24/2025)
2025-04-24
1
NOTICE OF SERVICE of Defendant Curio Bioscience, Inc.'s Supplemental Final Invalidity Contentions filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 04/29/2025)
2025-04-29
1
NOTICE OF SERVICE of Plaintiffs First Set of Requests for Admission to Curio (Nos. 1-14) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 04/30/2025)
2025-04-30
1
NOTICE to Take Deposition of Defendant Curio Bioscience, Inc. filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Rawnsley, Jason) (Entered: 04/30/2025)
2025-04-30
1
SECOND NOTICE to Take Deposition of Defendant Curio Bioscience, Inc. filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Rawnsley, Jason) Modified on 5/1/2025 (dlw). (Entered: 04/30/2025)
2025-04-30
1
NOTICE of Withdraw of Robert L. Gerrity by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Rawnsley, Jason) (Entered: 04/30/2025)
2025-04-30
1
MOTION for Pro Hac Vice Appearance of Attorney Madison Arent - filed by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 05/06/2025)
2025-05-06
1
Pro Hac Vice Fee - Credit Card Payment received for Madison Arent. ( re 102 MOTION for Pro Hac Vice Appearance of Attorney Madison Arent )( Payment of $ 50, receipt number ADEDC-4680234).(Farnan, Brian) (Entered: 05/06/2025)
2025-05-06
1
NOTICE OF SERVICE of Defendant Curio Bioscience, Inc.'s Final Non-Infringement Contentions filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/06/2025)
2025-05-06
1
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2025-05-06
1
No Actions
Add Attorneys - PHV only
2025-05-07
1
No Actions
SO ORDERED
2025-05-07
1
No Actions
SO ORDERED re 102 MOTION for Pro Hac Vice Appearance of Attorney Madison Arent filed by Curio Bioscience, Inc. ORDERED by Judge Maryellen Noreika on 5/7/2025. (dlw)
2025-05-07
1
No Actions
Pro Hac Vice Attorney Madison Arent for Curio Bioscience, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd)
2025-05-07
1
No Actions
NOTICE to Take Deposition of Mark Chee on a date mutually agreed upon filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/09/2025)
2025-05-09
1
NOTICE to Take Deposition of Serge Saxonov on a date mutually agreed upon filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/09/2025)
2025-05-09
1
NOTICE to Take Deposition of Augusto Tentori on a date mutually agreed upon filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/09/2025)
2025-05-09
1
NOTICE to Take Deposition of Eric Whitaker on a date mutually agreed upon filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/09/2025)
2025-05-09
1
NOTICE to Take Deposition of Randy Wu on a date mutually agreed upon filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/09/2025)
2025-05-09
1
NOTICE of Subpoenas for Service On: Aquilo Partners L.P.; Cooley LLP; Dorsey & Whitney LLP; Houlihan Lokey, Inc.; Vern Norviel; and Primer Ventures I, LP. by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) (Entered: 05/12/2025)
2025-05-12
1
NOTICE OF SERVICE of (1) Plaintiffs' Third Set of Interrogatories to Curio Bioscience, Inc. (Nos. 18-25); and (2) Plaintiffs' Second Set of Requests for Admission to Curio (Nos. 15-41) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Ewing, Alexandra) (Entered: 05/12/2025)
2025-05-12
1
[SEALED] NOTICE of Subpoena to Becton Dickinson and Company by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Subpoena to Becton Dickinson and Company, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Monasterio, Gabriela) Modified on 5/13/2025 (dlw). (Entered: 05/12/2025)
2025-05-12
1
MOTION for Pro Hac Vice Appearance of Attorney Priscilla Dodson - filed by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
Pro Hac Vice Fee - Credit Card Payment received for Priscilla Dodson. ( re 113 MOTION for Pro Hac Vice Appearance of Attorney Priscilla Dodson )( Payment of $ 50, receipt number ADEDC-4685042).(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
NOTICE OF SERVICE of Defendant's Fifth Set of Interrogatories to Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences Inc. (Nos. 10-18) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
NOTICE to Take Deposition of Zachary Bent on a date mutually agreed upon filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
NOTICE to Take Deposition of Ben Hindson on a date mutually agreed upon filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
NOTICE to Take Deposition of Michael Schnall-Levin on a date mutually agreed upon filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
NOTICE OF SERVICE of Defendant's Fourth Set of Requests for Production (Nos. 60-86) to Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences Inc. filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
CLAIM Construction Chart by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Ewing, Alexandra) (Entered: 05/13/2025)
2025-05-13
1
NOTICE to Take Deposition of 10x Genomics Inc. filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
NOTICE to Take Deposition of Ashley Benham filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
NOTICE to Take Deposition of Julia Cowen filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
NOTICE to Take Deposition of Peter Smibert filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/13/2025)
2025-05-13
1
SO ORDERED re 113 MOTION for Pro Hac Vice Appearance of Attorney Priscilla Dodson filed by Curio Bioscience, Inc. ORDERED by Judge Maryellen Noreika on 5/13/2025. (dlw)
2025-05-13
1
No Actions
Pro Hac Vice Attorney Priscilla G. Dodson for Curio Bioscience, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cdd)
2025-05-13
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2025-05-13
1
No Actions
SO ORDERED
2025-05-13
1
No Actions
- CORRECTING ENTRY
2025-05-13
1
No Actions
Add Attorneys - PHV only
2025-05-13
1
No Actions
CORRECTING ENTRY: D.I. 112 placed under seal per request of counsel. (rlr)
2025-05-13
1
No Actions
NOTICE to Take Deposition of Prognosys Biosciences, Inc. on a date mutually agreed upon filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/14/2025)
2025-05-14
1
NOTICE of Subpoena to Jason Young by Curio Bioscience, Inc. (Attachments: # 1 Exhibit A)(Farnan, Brian) (Entered: 05/14/2025)
2025-05-14
1
NOTICE OF SERVICE of (i) Defendant's First Set of Requests for Admission to Plaintiffs (Nos. 1-50) and (ii) Defendant's Sixth Set of Interrogatories to Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences Inc (Nos. 19-25) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/14/2025)
2025-05-14
1
NOTICE OF SERVICE of Defendant's Second Amended Initial Disclosure Pursuant to Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/16/2025)
2025-05-16
1
NOTICE of of Subpoenas to Aquilo Partners L.P. and to Vern Norviel by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Subpoena to Aquilo Partners L.P.,, # 2 Subpoena to Vern Norviel)(Monasterio, Gabriela) (Entered: 05/21/2025)
2025-05-21
1
NOTICE to Take Deposition of Jacob Stern on a date mutually agreed upon filed by Curio Bioscience, Inc.. (Attachments: # 1 Exhibit A)(Farnan, Brian) (Entered: 05/22/2025)
2025-05-22
1
NOTICE OF SERVICE of Defendant's Second Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/23/2025)
2025-05-23
1
NOTICE OF SERVICE of Defendant Curio Bioscience, Inc.'s Objections and Responses to Plaintiffs' Second Set of Interrogatories (Nos. 5-17) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/27/2025)
2025-05-27
1
AMENDED NOTICE to Take Deposition of Randy Wu on 5/30/2025 filed by Curio Bioscience, Inc. (Farnan, Brian) Modified on 5/28/2025 (dlw). (Entered: 05/27/2025)
2025-05-27
1
NOTICE of Subpoenas by 10X Genomics, Inc. (Attachments: # 1 Subpoena to Ari Chaney, # 2 Subpoena to Bertrand Yeung, # 3 Subpoena to Stephen Fodor)(Ewing, Alexandra) (Entered: 05/27/2025)
2025-05-27
1
NOTICE of Subpoenas by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Attachment 1, # 2 Attachment 2, # 3 Attachment 3, # 4 Attachment 4, # 5 Attachment 5, # 6 Attachment 6, # 7 Attachment 7, # 8 Attachment 8)(Ewing, Alexandra) (Entered: 05/28/2025)
2025-05-28
1
NOTICE OF SERVICE of Plaintiffs Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 05/29/2025)
2025-05-29
1
NOTICE OF SERVICE of Defendant Curio Bioscience, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for Admission to Curio (Nos. 1-14) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 05/30/2025)
2025-05-30
1
NOTICE to Take Deposition of Neil Kennedy, Stephen Fodor, Christina Fan, Wanxin Wang, Bertrand Yeung, Christina Chang, Ivan Wong, Ari Chaney and Anaram Shahravan Purusant to Federal Rules of Civil Procedure 26 and 30(b)(1) on Various Dates filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 06/02/2025)
2025-06-02
1
AMENDED NOTICE to Take Deposition of Augusto Tentori on June 6, 2025 filed by Curio Bioscience, Inc. (Farnan, Brian) Modified on 6/4/2025 (dlw). (Entered: 06/04/2025)
2025-06-04
1
AMENDED NOTICE to Take Deposition of Jason Young on June 6, 2025 filed by Curio Bioscience, Inc. (Farnan, Brian) Modified on 6/4/2025 (dlw). (Entered: 06/04/2025)
2025-06-04
1
AMENDED NOTICE to Take Deposition of Peter Smibert on June 9, 2025 filed by Curio Bioscience, Inc. (Farnan, Brian) Modified on 6/4/2025 (dlw). (Entered: 06/04/2025)
2025-06-04
1
MOTION for Pro Hac Vice Appearance of Attorney Daniel Kazhdan and Natasha M. Saputo - filed by 10X Genomics, Inc.. (Ewing, Alexandra) (Entered: 06/04/2025)
2025-06-04
1
Pro Hac Vice Fee - Credit Card Payment received for Daniel Kazhdan and Natasha M. Saputo. ( re 142 MOTION for Pro Hac Vice Appearance of Attorney Daniel Kazhdan and Natasha M. Saputo )( Payment of $ 100, receipt number ADEDC-4703127).(Ewing, Alexandra) (Entered: 06/04/2025)
2025-06-04
1
-District Court Pro Hac Vice Fee - 02 Attorneys Credit Card Payment
2025-06-04
1
No Actions
SO ORDERED
2025-06-04
1
No Actions
SO ORDERED re 142 MOTION for Pro Hac Vice Appearance of Attorney Daniel Kazhdan and Natasha M. Saputo filed by 10X Genomics, Inc. ORDERED by Judge Maryellen Noreika on 6/4/2025. (dlw)
2025-06-04
1
No Actions
NOTICE OF SERVICE of Plaintiffs Second Supplemental Objections and Responses to Curios Second Set of Interrogatories (Nos. 2-4) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 06/06/2025)
2025-06-06
1
Pro Hac Vice Attorney Natasha M. Saputo & Daniel Kazhdan for 10X Genomics, Inc. & Prognosys Biosciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk)
2025-06-06
1
No Actions
Add Attorneys - PHV only
2025-06-06
1
No Actions
NOTICE to Take Deposition of Ashley Benham on June 12, 2025 filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/08/2025)
2025-06-08
1
NOTICE to Take Deposition of Jacob Stern on June 24, 2025 filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/08/2025)
2025-06-08
1
NOTICE to Take Deposition of Julia Cowen on June 10, 2025 filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/08/2025)
2025-06-08
1
NOTICE to Take Deposition of Mark Chee on June 13, 2025 filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/08/2025)
2025-06-08
1
NOTICE to Take Deposition of Nate Veldkamp on June 13, 2025 filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/08/2025)
2025-06-08
1
NOTICE to Take Deposition of Ben Hindson on 6/11/2025 (Amended) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/09/2025)
2025-06-09
1
NOTICE to Take Deposition of Eric Whitaker on 6/18/2025 filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/09/2025)
2025-06-09
1
NOTICE OF SERVICE of (i) Curio Bioscience, Inc.'s Objections to Plaintiffs' First 30(b)(6) Deposition Notice and (ii) Curio Bioscience, Inc.'s Objections to Plaintiffs' Second 30(b)(6) Deposition Notice filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/09/2025)
2025-06-09
1
STIPULATION and [Proposed] Order for Briefing Schedule Regarding the Saxonov Deposition Dispute by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Ewing, Alexandra) (Entered: 06/09/2025)
2025-06-09
1
[SEALED] Letter to the Honorable Maryellen Noreika from Alexandra M. Ewing regarding Letter re: Motion for a Protective Order regarding the Deposition of Serge Saxonov. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Ewing, Alexandra) (Entered: 06/09/2025)
2025-06-09
1
NOTICE OF SERVICE of Defendant's Supplemental Objections and Responses to Plaintiffs' Second Set of Interrogatories to Curio Bioscience, Inc. (Nos. 5-17) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/10/2025)
2025-06-10
1
NOTICE of Depositions of Danh Tran, Jane Clarke, Cedric Uytingco, and Robert Stone by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Ewing, Alexandra) (Entered: 06/10/2025)
2025-06-10
1
NOTICE of Amended Notice of Depositions of Christina Fan, Anaram Shahravan, and Neil Kennedy by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Ewing, Alexandra) (Entered: 06/10/2025)
2025-06-10
1
SO ORDERED
2025-06-10
1
No Actions
SO ORDERED re 153 Stipulation and Order for Briefing Schedule Regarding the Serge Saxonov Deposition Dispute. ORDERED by Judge Maryellen Noreika on 6/10/2025. (dlw)
2025-06-10
1
No Actions
AMENDED NOTICE to Take Deposition of Mark Chee on 6/13/2025 (Amended) filed by Curio Bioscience, Inc. (Farnan, Brian) Modified on 6/11/2025 (dlw). (Entered: 06/11/2025)
2025-06-11
1
NOTICE OF SERVICE of (i) Defendant Curio Bioscience, Inc.'s Objections and Responses to Plaintiffs' Second Set of Requests for Admission to Curio (Nos. 15-41) and (ii) Defendant's Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 18-25) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 06/11/2025)
2025-06-11
1
[SEALED] Letter to The Honorable Maryellen Noreika from Brian E. Farnan regarding Response to Plaintiffs' Motion for a Protective Order Regarding the Deposition of Serge Saxonov - re 154 Letter,. (Farnan, Brian) (Entered: 06/13/2025)
2025-06-13
1
[SEALED] DECLARATION of Andrew Krause re 160 Letter by Curio Bioscience, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Certificate of Service)(Farnan, Brian) (Entered: 06/13/2025)
2025-06-13
1
NOTICE OF SERVICE of Plaintiffs Objections and Responses to Defendants Sixth Set of Interrogatories (Nos. 19-25); Third Supplemental Objections and Responses to Second Set of Interrogatories (Nos. 2-4); First Supplemental Objections and Responses to Fourth Set of Interrogatories (Nos. 6-9); Objections and Responses to First Set of Requests for Admission (Nos. 1-50); Second Supplemental Initial Disclosures; Third Supplemental Objections and Responses to First Set of Interrogatories (No. 1) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 06/13/2025)
2025-06-13
1
STIPULATION To Extend Deadlines and Modify Case Schedule by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Monasterio, Gabriela) (Entered: 06/13/2025)
2025-06-13
1
SO ORDERED re 163 Stipulation and Order to Extend Close of Fact Discovery (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 6/24/2025). Signed by Judge Maryellen Noreika on 6/16/2025. (dlw) (Entered: 06/16/2025)
2025-06-16
1
ORAL ORDER Setting Teleconference re 154 Letter, 160 Letter, 83 Motion to Bifurcate and Stay - IT IS HEREBY ORDERED that a Telephone Conference is set for 6/20/2025 at 10:00 AM before Judge Maryellen Noreika to address the parties' dispute regarding the deposition of Serge Saxonov and to hear argument on the pending Motion to Bifurcate and Stay. The Court is setting aside 15 minutes per side for the argument on the motion. Counsel shall provide a teleconference dial-in number and code for the teleconference by emailing this Court's judicial administrator. ORDERED by Judge Maryellen Noreika on 6/16/2025. (dlw) (Entered: 06/16/2025)
2025-06-16
1
AMENDED NOTICE to Take Deposition of Michael Schnall-Levin on June 17, 2025 filed by Curio Bioscience, Inc. (Farnan, Michael) Modified on 6/16/2025 (dlw). (Entered: 06/16/2025)
2025-06-16
1
REDACTED VERSION of 154 Letter, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A through E, # 2 Exhibit F, # 3 Exhibit G through I)(Monasterio, Gabriela) (Entered: 06/16/2025)
2025-06-16
1
AMENDED NOTICE to Take Deposition of Jane Clarke Pursuant to Federal Rules of Civil Procedure 26 and 30(b)(1) on June 17, 2025 filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) Modified on 6/17/2025 (dlw). (Entered: 06/16/2025)
2025-06-16
1
Order Setting Teleconference
2025-06-16
1
No Actions
NOTICE of Amended Notice of Deposition of Christina Chang by 10X Genomics, Inc., Prognosys Biosciences, Inc. re 138 Notice to Take Deposition, (Ewing, Alexandra) (Entered: 06/17/2025)
2025-06-17
1
NOTICE to Take Deposition of Anaram Shahravan on June 20, 2025 (Amended) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 06/19/2025)
2025-06-19
1
REDACTED VERSION of 160 Letter by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 06/20/2025)
2025-06-20
1
REDACTED VERSION of 161 Declaration, by Curio Bioscience, Inc.. (Attachments: # 1 Exhibits A-H)(Farnan, Brian) (Entered: 06/20/2025)
2025-06-20
1
Minute Entry for proceedings held before Judge Maryellen Noreika - Telephonic Motion Hearing held on 6/20/2025. Arguments heard on the plaintiffs' motion for a protective order ( 154, 160 ), and motion to bifurcate and stay ( 83 ). After hearing arguments on Motions, the request for a protective order is DENIED and the motion to stay and bifurcate is GRANTED-IN-PART. The antitrust counterclaims are STAYED as to expert discovery and trial. The transcript shall serve as the Court's order. (Court Reporter Dale Hawkins.) (mdb)
2025-06-20
1
No Actions
Telephone Conference AND ~Util - Terminate Motions
2025-06-20
1
No Actions
STIPULATION TO EXTEND TIME Fact Discovery to July 11, 2025 - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Monasterio, Gabriela) (Entered: 07/01/2025)
2025-07-01
1
SO ORDERED re 173 STIPULATION TO EXTEND Fact Discovery Deadline to July 11, 2025 (Set/Reset Scheduling Order Deadlines - Fact Discovery completed by 7/11/2025). Signed by Judge Maryellen Noreika on 7/2/2025. (dlw) (Entered: 07/02/2025)
2025-07-02
1
NOTICE to Take Deposition of Serge Saxonov on 7/11/2025 filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 07/07/2025)
2025-07-07
1
AMENDED NOTICE to Take Deposition of Ari Chaney on July 11, 2025 filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) Modified on 7/11/2025 (dlw). (Entered: 07/10/2025)
2025-07-10
1
[SEALED] SUBPOENA filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. directed to Matthew Dowd for August 13, 2025 (Attachments: # 1 Exhibit A)(Monasterio, Gabriela) (Entered: 07/24/2025)
2025-07-24
1
NOTICE to Take Deposition of Matthew Dowd on August 13, 2025 filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 07/24/2025)
2025-07-24
1
[SEALED] SUBPOENA filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. directed to Dowd Scheffel PLLC for August 13, 2025 (Attachments: # 1 Exhibit A)(Monasterio, Gabriela) (Entered: 07/24/2025)
2025-07-24
1
[SEALED] NOTICE to Take Deposition of Dowd Scheffel PLLC on August 13, 2025 filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) Modified on 8/5/2025 (mdb). (Entered: 07/24/2025)
2025-07-24
1
NOTICE to Take Deposition of Vern Norviel on 7/29/2025 filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 07/28/2025)
2025-07-28
1
SECOND AMENDED Notice of Deposition of Ivan Wong on 7/29/2025. (Monasterio, Gabriela) Modified on 7/28/2025 (dlw). (Entered: 07/28/2025)
2025-07-28
1
NOTICE OF SERVICE of (i) Defendant's Supplemental Objections and Responses to Plaintiffs' Second Set of Interrogatories to Curio Bioscience, Inc. (Nos. 5-17) and (ii) Defendant's Third Supplemental Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-4) filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 08/01/2025)
2025-08-01
1
NOTICE to Take Deposition of Stephen Fodor on August 7, 2025 at 9 AM EDT filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Ewing, Alexandra) (Entered: 08/04/2025)
2025-08-04
1
[SEALED] Joint STIPULATION to Join Takara Bio USA, Inc. and Takara Bio USA Holdings, Inc. as Defendants and to permit supplementation of Plaintiffs infringement contentions and Defendants non-infringement contentions by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Monasterio, Gabriela) (Entered: 08/04/2025)
2025-08-04
1
STIPULATION TO EXTEND TIME to Submit Redacted Versions of DI 177 and 179 to August 5, 2025 - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Monasterio, Gabriela) (Entered: 08/04/2025)
2025-08-04
1
REDACTED VERSION of 177 Subpoena by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A)(Monasterio, Gabriela) (Entered: 08/05/2025)
2025-08-05
1
REDACTED VERSION of 179 Subpoena directed to Dowd Scheffel PLLC by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A)(Monasterio, Gabriela) Modified on 8/6/2025 (mdb). (Entered: 08/05/2025)
2025-08-05
1
CORRECTING ENTRY: The Notice to Take Deposition ( 180 ) has been placed under seal at the request of counsel. (mdb)
2025-08-05
1
No Actions
- CORRECTING ENTRY
2025-08-05
1
No Actions
SO ORDERED
2025-08-05
1
No Actions
SO ORDERED, re 186 STIPULATION TO EXTEND TIME to Submit Redacted Versions of DI 177 and 179 to August 5, 2025. ORDERED by Judge Maryellen Noreika on 8/5/2025. (mdb)
2025-08-05
1
No Actions
[SEALED] SO ORDERED, re 185 Joint Stipulation to Join Takara Bio USA, Inc. and Takara Bio USA Holdings, Inc. as Defendants and to permit supplementation of Plaintiffs infringement contentions and Defendants non-infringement contentions, filed by 10X Genomics, Inc., Prognosys Biosciences, Inc., Takara Bio USA, Inc. and Takara Bio USA Holdings, Inc. added. Signed by Judge Maryellen Noreika on 8/6/2025. This order has been emailed to local counsel. (mdb) (Entered: 08/06/2025)
2025-08-06
1
Letter to The Hon. Maryellen Norieka from All Counsel of Record regarding Markman Hearing. (Rawnsley, Jason) (Entered: 08/06/2025)
2025-08-06
1
Amended Joint CLAIM Construction Chart re 120 Claim Construction Chart. (Rawnsley, Jason) Modified on 8/6/2025 (mdb). (Entered: 08/06/2025)
2025-08-06
1
Letter to The Honorable Maryellen Noreika from Michael J. Farnan regarding Curio's Technology Tutorial. (Farnan, Michael) (Entered: 08/06/2025)
2025-08-06
1
NOTICE of Lodging by 10X Genomics, Inc. (Attachments: # 1 Exhibit Plaintiff's Technology Tutorial)(Ewing, Alexandra) (Entered: 08/06/2025)
2025-08-06
1
[SEALED] JOINT CLAIM CONSTRUCTION BRIEF filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 08/06/2025)
2025-08-06
1
[SEALED] Joint APPENDIX Volume I by 10X Genomics, Inc.. (Attachments: # 1 Exhibit A0001, # 2 Exhibit A0089, # 3 Exhibit A0121, # 4 Exhibit A0152, # 5 Exhibit A0184, # 6 Exhibit A0225, # 7 Exhibit A0268, # 8 Exhibit A0282, # 9 Exhibit A0315, # 10 Exhibit A0353)(Monasterio, Gabriela) Modified on 8/7/2025 (mdb). (Entered: 08/06/2025)
2025-08-06
1
[SEALED] Joint APPENDIX Volume II by 10X Genomics, Inc.. (Attachments: # 1 Exhibit A0390, # 2 Exhibit A0414, # 3 Exhibit A0424, # 4 Exhibit A0458, # 5 Exhibit A0476, # 6 Exhibit A0522, # 7 Exhibit A0564, # 8 Exhibit A0575, # 9 Exhibit A0615)(Monasterio, Gabriela) Modified on 8/7/2025 (mdb). (Entered: 08/06/2025)
2025-08-06
1
[SEALED] APPENDIX Volume III of VIII by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A0645-A0676, # 2 Exhibit A0677-A0688, # 3 Exhibit A0689-A0694, # 4 Exhibit A0695-A0726)(Rawnsley, Jason) Modified on 8/7/2025 (mdb). (Entered: 08/06/2025)
2025-08-06
1
[SEALED] Joint APPENDIX Volume IV of VIII by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A0727-A0735, # 2 Exhibit A0736-A0738, # 3 Exhibit A0739-A0752, # 4 Exhibit A0753-A0884, # 5 Exhibit A0885-A0955, # 6 Exhibit A0956-A0966, # 7 Exhibit A0967-A1010, # 8 Exhibit A1011-A1055, # 9 Exhibit A1056-A1071, # 10 Exhibit A1072-A1078, # 11 Exhibit A1079-A1081, # 12 Exhibit A1082-A1091, # 13 Exhibit A1092-A1112)(Rawnsley, Jason) Modified on 8/7/2025 (mdb). (Entered: 08/06/2025)
2025-08-06
1
[SEALED] Joint APPENDIX Volume V of VIII by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A1113, # 2 Exhibit A1123, # 3 Exhibit A1185, # 4 Exhibit A2068, # 5 Exhibit A2154, # 6 Exhibit A2187, # 7 Exhibit A2207, # 8 Exhibit A2284, # 9 Exhibit A2368, # 10 Exhibit A2447, # 11 Exhibit A2526)(Rawnsley, Jason) Modified on 8/7/2025 (mdb). (Entered: 08/06/2025)
2025-08-06
1
[SEALED] Joint APPENDIX Volume VI of VIII by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A2559, # 2 Exhibit A2591, # 3 Exhibit A2622, # 4 Exhibit A2656, # 5 Exhibit A2689, # 6 Exhibit A2722, # 7 Exhibit A2755, # 8 Exhibit A2787, # 9 Exhibit A2823, # 10 Exhibit A2863, # 11 Exhibit A2902, # 12 Exhibit A2942, # 13 Exhibit A3012, # 14 Exhibit A3018, # 15 Exhibit A3048, # 16 Exhibit A3077)(Rawnsley, Jason) Modified on 8/7/2025 (mdb). (Entered: 08/06/2025)
2025-08-06
1
[SEALED] Joint APPENDIX Volume VII of VIII by Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A3095, # 2 Exhibit A3104, # 3 Exhibit A3185, # 4 Exhibit A3192, # 5 Exhibit A3199, # 6 Exhibit A3206, # 7 Exhibit A3214, # 8 Exhibit A3235, # 9 Exhibit A3243, # 10 Exhibit A3265, # 11 Exhibit A3273, # 12 Exhibit A3296, # 13 Exhibit A3311, # 14 Exhibit A3322, # 15 Exhibit A3355, # 16 Exhibit A3384, # 17 Exhibit A3391, # 18 Exhibit A3408, # 19 Exhibit A3455, # 20 Exhibit A3469, # 21 Exhibit A3487, # 22 Exhibit A3496, # 23 Exhibit A3505, # 24 Exhibit A3533, # 25 Exhibit A3560, # 26 Exhibit A3567, # 27 Exhibit A3574, # 28 Exhibit A3618, # 29 Exhibit A3626)(Rawnsley, Jason) Modified on 8/7/2025 (mdb). (Entered: 08/06/2025)
2025-08-06
1
[SEALED] Joint APPENDIX Volume VIII of VIII by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A3632, # 2 Exhibit A3652, # 3 Exhibit A3676, # 4 Exhibit A3700, # 5 Exhibit A3711, # 6 Exhibit A3721, # 7 Exhibit A3776)(Rawnsley, Jason) Modified on 8/7/2025 (mdb). (Entered: 08/06/2025)
2025-08-06
1
REDACTED VERSION of 180 Notice to Take Deposition by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) Modified on 8/11/2025 (dlw). (Entered: 08/08/2025)
2025-08-08
1
NOTICE of Service of (1) Plaintiffs Second Supplemental Identification of Accused Products and (2) this Notice of Service by 10X Genomics, Inc. (Ewing, Alexandra) (Entered: 08/11/2025)
2025-08-11
1
REDACTED VERSION of 185 Stipulation by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Monasterio, Gabriela) Modified on 8/11/2025 (dlw). (Entered: 08/11/2025)
2025-08-11
1
REDACTED VERSION of 189 SO ORDERED,, Add and Terminate Parties, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Monasterio, Gabriela) (Entered: 08/11/2025)
2025-08-11
1
ORAL ORDER re 190 Letter - IT IS HEREBY ORDERED that the Court is setting aside two (2) hours for the 8/27/2025 claim construction hearing with the time split as described in the letter. IT IS FURTHER ORDERED that any slide presentations the parties wish to use during the hearing shall be emailed (in PDF format) to MN_civil@ded.uscourts.gov no later than 24 hours prior to the hearing with hard copies delivered to the Clerk's Office within one (1) hour thereafter. Counsel may, however, agree upon a different time to exchange their respective slides. ORDERED by Judge Maryellen Noreika on 8/12/2025. (dlw) (Entered: 08/12/2025)
2025-08-12
1
ORAL ORDER - Consistent with the Scheduling Order, the parties contacted Chambers via email on 8/8/2025 requesting a teleconference date for two discovery disputes. IT IS HEREBY ORDERED that these disputes will be heard at the 8/27/2025 claim construction hearing. The opening letter, not to exceed three pages, is due no later than 8/18/2025 and the answering letter, not to exceed three pages, is due no later than 8/22/2025. ORDERED by Judge Maryellen Noreika on 8/12/2025. (dlw) (Entered: 08/12/2025)
2025-08-12
1
Oral Order
2025-08-12
1
No Actions
REDACTED VERSION of 194 Joint Claim Construction Brief by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Monasterio, Gabriela) (Entered: 08/13/2025)
2025-08-13
1
REDACTED VERSION of 195 Appendix, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A0001, # 2 Exhibit A0089, # 3 Exhibit A0121, # 4 Exhibit A0152, # 5 Exhibit A0184, # 6 Exhibit A0225, # 7 Exhibit A0268, # 8 Exhibit A0282, # 9 Exhibit A0315, # 10 Exhibit A0353)(Monasterio, Gabriela) (Entered: 08/13/2025)
2025-08-13
1
REDACTED VERSION of 196 Appendix, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A0390, # 2 Exhibit A0414, # 3 Exhibit A0424, # 4 Exhibit A0458, # 5 Exhibit A0476, # 6 Exhibit A0522, # 7 Exhibit A0564, # 8 Exhibit A0575, # 9 Exhibit A0615)(Monasterio, Gabriela) (Entered: 08/13/2025)
2025-08-13
1
REDACTED VERSION of 197 Appendix, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A0645, # 2 Exhibit A0677, # 3 Exhibit A0689, # 4 Exhibit A0695)(Monasterio, Gabriela) (Entered: 08/13/2025)
2025-08-13
1
REDACTED VERSION of 198 Appendix,, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A0727, # 2 Exhibit A0736, # 3 Exhibit A0739, # 4 Exhibit A0753, # 5 Exhibit A0885, # 6 Exhibit A0956, # 7 Exhibit A0967, # 8 Exhibit A1011, # 9 Exhibit A1056, # 10 Exhibit A1072, # 11 Exhibit A1079, # 12 Exhibit A1082, # 13 Exhibit A1092)(Monasterio, Gabriela) (Entered: 08/13/2025)
2025-08-13
1
REDACTED VERSION of 199 Appendix, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A1113, # 2 Exhibit A1123, # 3 Exhibit A1185, # 4 Exhibit A2068, # 5 Exhibit A2154, # 6 Exhibit A2187, # 7 Exhibit A2207, # 8 Exhibit A2284, # 9 Exhibit A2368, # 10 Exhibit A2447, # 11 Exhibit A2526)(Monasterio, Gabriela) (Entered: 08/13/2025)
2025-08-13
1
REDACTED VERSION of 200 Appendix,, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A2559, # 2 Exhibit A2591, # 3 Exhibit A2622, # 4 Exhibit A2656, # 5 Exhibit A2689, # 6 Exhibit A2722, # 7 Exhibit A2755, # 8 Exhibit A2787, # 9 Exhibit A2823, # 10 Exhibit A2863, # 11 Exhibit A2902, # 12 Exhibit A2942, # 13 Exhibit A3012, # 14 Exhibit A3018, # 15 Exhibit A3048, # 16 Exhibit A3077)(Monasterio, Gabriela) (Entered: 08/13/2025)
2025-08-13
1
REDACTED VERSION of 201 Appendix,,, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A3095, # 2 Exhibit A3104, # 3 Exhibit A3185, # 4 Exhibit A3192, # 5 Exhibit A3199, # 6 Exhibit A3206, # 7 Exhibit A3214, # 8 Exhibit A3235, # 9 Exhibit A3243, # 10 Exhibit A3265, # 11 Exhibit A3273, # 12 Exhibit A3296, # 13 Exhibit A3311, # 14 Exhibit A3322, # 15 Exhibit A3355, # 16 Exhibit A3384, # 17 Exhibit A3391, # 18 Exhibit A3408, # 19 Exhibit A3455, # 20 Exhibit A3469, # 21 Exhibit A3487, # 22 Exhibit A3496, # 23 Exhibit A3505, # 24 Exhibit A3533, # 25 Exhibit A3560, # 26 Exhibit A3567, # 27 Exhibit A3574, # 28 Exhibit A3618, # 29 Exhibit A3626)(Monasterio, Gabriela) (Entered: 08/13/2025)
2025-08-13
1
REDACTED VERSION of 202 Appendix, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A3632, # 2 Exhibit A3652, # 3 Exhibit A3676, # 4 Exhibit A3700, # 5 Exhibit A3711, # 6 Exhibit A3721, # 7 Exhibit A3776)(Monasterio, Gabriela) (Entered: 08/13/2025)
2025-08-13
1
[SEALED] Letter to The Hon. Maryellen Noreika from Frederick L. Cottrell III, Esq. regarding Discovery Disputes. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Cottrell, Frederick) (Entered: 08/18/2025)
2025-08-18
1
MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices for Markman Hearing - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Ewing, Alexandra) (Main Document 219 replaced on 8/21/2025) (dlw). (Entered: 08/21/2025)
2025-08-21
1
ORDER GRANTING 219 Plaintiffs' MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices for Markman Hearing. Signed by Judge Maryellen Noreika on 8/21/2025. (dlw) (Entered: 08/21/2025)
2025-08-21
1
[SEALED] Letter to The Honorable Maryellen Noreika from Brian E. Farnan regarding Response to Plaintiffs' August 18, 2025 Letter - re 218 Letter,. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit D, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit M-1, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R)(Farnan, Brian) (Entered: 08/22/2025)
2025-08-22
1
STIPULATION Motion and [Proposed] Order to Extend Close of Fact Discovery by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Ewing, Alexandra) (Entered: 08/22/2025)
2025-08-22
1
SO ORDERED re 222 Stipulated Motion and Order to Extend Close of Fact Discovery (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 9/12/2025). Signed by Judge Maryellen Noreika on 8/25/2025. (dlw) (Entered: 08/25/2025)
2025-08-25
1
REDACTED VERSION of 218 Letter by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Ewing, Alexandra) Modified on 8/26/2025 (dlw). (Entered: 08/25/2025)
2025-08-25
1
Markman Hearing
2025-08-27
1
No Actions
Minute Entry for proceedings held before Judge Maryellen Noreika - Markman Hearing held on 8/27/2025. The Court also heard arguments on the discovery disputes ( 218, 221 ). See transcript for more details. (Court Reporter Dale Hawkins.) (mdb)
2025-08-27
1
No Actions
Official Transcript of Markman Hearing held on 08/27/2025 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/19/2025. Redacted Transcript Deadline set for 9/29/2025. Release of Transcript Restriction set for 12/1/2025. (dh) (Entered: 08/29/2025)
2025-08-29
1
REDACTED VERSION of 221 Letter,, by Curio Bioscience, Inc.. (Attachments: # 1 Exhibits A-R)(Farnan, Brian) (Entered: 08/29/2025)
2025-08-29
1
NOTICE of Deposition of Carol Lou Pursuant to Federal Rules of Civil Procedure 30(b)(1) by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Ewing, Alexandra) (Entered: 09/03/2025)
2025-09-03
1
REDACTED VERSION of 112 Notice by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Subpoena to Becton Dickinson and Company, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C)(Monasterio, Gabriela) Modified on 9/9/2025 (dlw). (Entered: 09/09/2025)
2025-09-09
1
NOTICE OF SERVICE of (1) Second Supplemental Responses and Objections to Curios Fourth Set of Interrogatories; (2) Fourth Supplemental Objections and Responses to Curios Second Set of Interrogatories; (3) First Supplemental Responses and Objections to Curios Fifth Set of Interrogatories; and (4) this Notice of Service filed by Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 09/26/2025)
2025-09-26
1
NOTICE OF SERVICE of The Expert Reports of John Quackenbush, PhD and the Expert Report and Disclosure of Julie L. Davis filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 09/30/2025)
2025-09-30
1
NOTICE OF SERVICE of Opening Expert Report of Dr. Joseph D. (Jody) Puglisi Regarding Invalidity of the Asserted Patents filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc..(Farnan, Brian) (Entered: 09/30/2025)
2025-09-30
1
NOTICE requesting Clerk to remove Paul Enriquez as co-counsel.. (Farnan, Brian) (Entered: 10/08/2025)
2025-10-08
1
STIPULATION TO EXTEND TIME to Extend Deadlines and Modify Case Schedule to various dates - filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Farnan, Michael) (Entered: 10/15/2025)
2025-10-15
1
SO ORDERED re 233 STIPULATION and Order to Extend Deadlines and Modify Case Schedule (Set/Reset Scheduling Order Deadlines: Rebuttal Expert Reports due by 10/31/2025. Reply Expert Reports due by 11/21/2025. Expert Discovery due by 12/9/2025. Dispositive Motions due by 12/12/2025. Answering Brief due 1/6/2026). Signed by Judge Maryellen Noreika on 10/16/2025. (dlw) (Entered: 10/16/2025)
2025-10-16
1
MOTION for Pro Hac Vice Appearance of Attorney Jeffrey B. Elikan, Eric R. Sonnenschein, Douglas A. Behrens, Allyson Corigliano, and Adam Smith - filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Farnan, Brian) (Entered: 10/17/2025)
2025-10-17
1
Pro Hac Vice Fee - Credit Card Payment received for Jeffrey B. Elikan, Eric R. Sonnenschein, Douglas A. Behrens, Allyson Corigliano, and Adam Smith. ( re 235 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey B. Elikan, Eric R. Sonnenschein, Douglas A. Behrens, Allyson Corigliano, and Adam Smith )( Payment of $ 250, receipt number ADEDC-4815030).(Farnan, Brian) (Entered: 10/17/2025)
2025-10-17
1
SO ORDERED
2025-10-17
1
No Actions
-District Court Pro Hac Vice Fee - 05 Attorneys Credit Card Payment
2025-10-17
1
No Actions
SO ORDERED re 235 MOTION for Pro Hac Vice Appearance of Attorney Jeffrey B. Elikan, Eric R. Sonnenschein, Douglas A. Behrens, Allyson Corigliano, and Adam Smith filed by Takara Bio USA, Inc., Curio Bioscience, Inc., Takara Bio USA Holdings, Inc. ORDERED by Judge Maryellen Noreika on 10/17/2025. (dlw)
2025-10-17
1
No Actions
NOTICE OF SERVICE of Defendants Curio Bioscience, Inc., Takara Bio USA, Inc., and Takara Bio USA Holdings, Inc.'s Supplemental Non-Infringement Contentions filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc..(Farnan, Brian) (Entered: 10/21/2025)
2025-10-21
1
Add Attorneys - PHV only
2025-10-22
1
No Actions
Pro Hac Vice Attorney Douglas A. Behrens, Allyson C. Corigliano, Jeffrey B. Elikan, Adam D. Smith, Eric R. Sonnenschein for Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (scs)
2025-10-22
1
No Actions
NOTICE OF SERVICE of Expert Report of Charles Cantor, Ph.D. filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 10/31/2025)
2025-10-31
1
NOTICE OF SERVICE of (i) Rebuttal Expert Report of Dr. Joseph D. (Jody) Puglisi Regarding Non-Infringement and Technical Issues Relating to Damages and (ii) Expert Rebuttal Report of Deforest McDuff, Ph.D. filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc..(Farnan, Brian) (Entered: 11/03/2025)
2025-11-03
1
NOTICE to Take Deposition of Andrew Farmer on November 13, 2025 filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 11/10/2025)
2025-11-10
1
NOTICE requesting Clerk to remove Morgan Chu, Alan Heinrich, Andrew Krause, and Abigail Sellers as co-counsel.. (Farnan, Brian) (Entered: 11/10/2025)
2025-11-10
1
AMENDED Notice to Take Deposition of Matthew Dowd. (Monasterio, Gabriela) Modified on 11/12/2025 (dlw). (Entered: 11/11/2025)
2025-11-11
1
NOTICE OF SERVICE of (1) the Reply Expert Report of John Quackenbush, Ph.D. and (2) the Reply Expert Report and Disclosure of Julie L. Davis filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Rawnsley, Jason) (Entered: 11/24/2025)
2025-11-24
1
NOTICE OF SERVICE of (i) Reply Expert Report of Joseph D. (Jody) Puglisi, Ph.D., Regarding Invalidity of the Asserted Patents and (ii) Expert Reply Report of Deforest McDuff, Ph.D. filed by Curio Bioscience, Inc..(Farnan, Brian) (Entered: 11/24/2025)
2025-11-24
1
STIPULATION TO EXTEND TIME (i) Expert Discovery; (ii) Summary Judgment and Daubert Motions; and (iii) Summary Judgment and Daubert Oppositions to (i) December 14, 2025; (ii) December 16, 2025; and (iii) January 8, 2026 - filed by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 11/25/2025)
2025-11-25
1
SO ORDERED re 245 STIPULATION TO EXTEND TIME (i) Expert Discovery; (ii) Summary Judgment and Daubert Motions; and (iii) Summary Judgment and Daubert Oppositions to (i) December 14, 2025; (ii) December 16, 2025; and (iii) January 8, 2026 (Set/Reset Scheduling Order Deadlines: Expert Discovery due by 12/14/2025. Dispositive Motions due by 12/16/2025. Answering Brief due 1/8/2026). Signed by Judge Maryellen Noreika on 11/26/2025. (dlw) (Entered: 11/26/2025)
2025-11-26
1
NOTICE of Service of the Notice of Subpoena to Irell & Manella LLP by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Ewing, Alexandra) (Entered: 12/01/2025)
2025-12-01
1
MOTION for Pro Hac Vice Appearance of Attorney Robert T. McMullen, Laura M. Martin, and Ian M. Hurst - filed by Curio Bioscience, Inc.. (Farnan, Brian) (Main Document 248 replaced on 12/3/2025) (dlw). (Entered: 12/03/2025)
2025-12-03
1
Pro Hac Vice Fee - Credit Card Payment received for Robert T. McMullen, Laura M. Martin, and Ian M. Hurst. ( re 248 MOTION for Pro Hac Vice Appearance of Attorney Robert T. McMullen, Laura M. Martin, and Ian M. Hurst )( Payment of $ 150, receipt number ADEDC-4850569).(Farnan, Brian) (Entered: 12/03/2025)
2025-12-03
1
-District Court Pro Hac Vice Fee - 03 Attorneys Credit Card Payment
2025-12-03
1
No Actions
- CORRECTING ENTRY
2025-12-03
1
No Actions
SO ORDERED
2025-12-03
1
No Actions
CORRECTING ENTRY: D.I. 248 has been replaced on the docket at the request of counsel to update the caption. (dlw)
2025-12-03
1
No Actions
SO ORDERED re 248 MOTION for Pro Hac Vice Appearance of Attorney Robert T. McMullen, Laura M. Martin, and Ian M. Hurst filed by Curio Bioscience, Inc. ORDERED by Judge Maryellen Noreika on 12/3/2025. (dlw)
2025-12-03
1
No Actions
Pro Hac Vice Attorney Laura M. Martin & Ian M. Hurst for Curio Bioscience, Inc., Takara Bio USA, Inc. & Takara Bio USA Holdings, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk)
2025-12-04
1
No Actions
Add Attorneys - PHV only
2025-12-04
1
No Actions
Pro Hac Vice Attorney Robert T. McMullen for Curio Bioscience, Inc., Takara Bio USA, Inc. & Takara Bio USA Holdings, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk)
2025-12-04
1
No Actions
NOTICE of Deposition of DeForest McDuff and Joseph Puglisi Pursuant to Federal Rules of Civil Procedure 30(b)(1) by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) (Entered: 12/09/2025)
2025-12-09
1
STIPULATED Motion and [Proposed] Order to Extend Close of Fact Discovery by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) Modified on 12/10/2025 (dlw). (Entered: 12/10/2025)
2025-12-10
1
SO ORDERED re 251 Stipulated Motion and Order to Extend Close of Fact Discovery (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 12/16/2025). Signed by Judge Maryellen Noreika on 12/10/2025. (dlw) (Entered: 12/10/2025)
2025-12-10
1
STIPULATION and [Proposed] Order Regarding Supplemental Expert Report by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Ewing, Alexandra) (Entered: 12/15/2025)
2025-12-15
1
SO ORDERED re 253 Stipulation and Order Regarding Supplemental Expert Report. Signed by Judge Maryellen Noreika on 12/15/2025. (dlw) (Entered: 12/15/2025)
2025-12-15
1
MOTION for Partial Summary Judgment - filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Text of Proposed Order)(Farnan, Brian) (Entered: 12/16/2025)
2025-12-16
1
MOTION for Partial Summary Judgment - filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Text of Proposed Order)(Farnan, Brian) (Entered: 12/16/2025)
2025-12-16
2
[SEALED] OPENING BRIEF in Support re 255 MOTION for Partial Summary Judgment filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc. Answering Brief/Response due date per 246 Stipulation and Order is 1/8/2026. (Attachments: # 1 Certificate of Service)(Farnan, Michael) Modified on 12/17/2025 (dlw). (Main Document 256 replaced on 2/2/2026) (dlw). (Entered: 12/16/2025)
2025-12-16
1
[SEALED] STATEMENT of Undisputed Material Facts re 255 MOTION for Partial Summary Judgment by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc. (Attachments: # 1 Certificate of Service)(Farnan, Michael) Modified on 12/17/2025 (dlw). (Main Document 257 replaced on 2/2/2026) (dlw). (Entered: 12/16/2025)
2025-12-16
1
[SEALED] DECLARATION of Ian M. Hurst in Support of Defendants' Motion for Partial Summary Judgment re 256 Opening Brief in Support, by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Certificate of Service)(Farnan, Michael) (Entered: 12/16/2025)
2025-12-16
1
NOTICE OF SERVICE of Plaintiffs' Third Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Plaintiffs' Second Supplemental Responses and Objections to Defendant's Fifth Set of Interrogatories (Nos. 10-18) filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 12/16/2025)
2025-12-16
1
REDACTED VERSION of 256 Opening Brief in Support, by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 12/23/2025)
2025-12-23
1
REDACTED VERSION of 257 Statement, by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 12/23/2025)
2025-12-23
1
REDACTED VERSION of 258 Declaration,, by Curio Bioscience, Inc.. (Attachments: # 1 Exhibits A-P)(Farnan, Brian) (Entered: 12/23/2025)
2025-12-23
1
REDACTED VERSION of 258 Declaration,, by Curio Bioscience, Inc.. (Attachments: # 1 Exhibits A-P)(Farnan, Brian) (Entered: 12/23/2025)
2025-12-23
2
NOTICE to Take Deposition of Ivan Wong on January 15, 2026 filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 12/23/2025)
2025-12-23
1
NOTICE OF SERVICE of Surreply Expert Report of Rahul Satija, D. Phil. filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Rawnsley, Jason) (Entered: 12/30/2025)
2025-12-30
1
[SEALED] ANSWERING BRIEF in Opposition re 255 MOTION for Partial Summary Judgment filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..Reply Brief due date per Local Rules is 1/15/2026. (Rawnsley, Jason) (Entered: 01/08/2026)
2026-01-08
1
[SEALED] STATEMENT of Disputed Material Facts by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Rawnsley, Jason) Modified on 1/9/2026 (dlw). (Entered: 01/08/2026)
2026-01-08
1
[SEALED] Response in Opposition re 257 Defendants' Statement of Undisputed Material Facts in Support of their Motion for Partial Summary Judgment by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Rawnsley, Jason) Modified on 1/9/2026 (dlw). (Entered: 01/08/2026)
2026-01-08
1
[SEALED] DECLARATION of Li Shen re 265 Answering Brief in Opposition by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Rawnsley, Jason) (Attachment 4 replaced on 1/9/2026) (dlw). (Entered: 01/08/2026)
2026-01-08
1
[SEALED] DECLARATION of John Quackenbush re 265 Answering Brief in Opposition by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Rawnsley, Jason) (Entered: 01/08/2026)
2026-01-08
1
[SEALED] DECLARATION of Rahul Satija re 265 Answering Brief in Opposition by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit A)(Rawnsley, Jason) (Entered: 01/08/2026)
2026-01-08
1
[SEALED] REPLY BRIEF re 255 MOTION for Partial Summary Judgment filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Michael) (Entered: 01/13/2026)
2026-01-13
1
[SEALED] STATEMENT re 271 Reply Brief // Defendants' Reply to Plaintiffs' Statement of Facts in Support of Defendants' Reply Brief in Support of Defendants' Motion for Partial Summary Judgment by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc. (Attachments: # 1 Certificate of Service)(Farnan, Michael) Modified on 1/15/2026 (dlw). (Entered: 01/13/2026)
2026-01-13
1
[SEALED] DECLARATION of Ian M. Hurst re 271 Reply Brief by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Exhibit Q, # 2 Exhibit R, # 3 Exhibit S, # 4 Exhibit T, # 5 Exhibit U, # 6 Certificate of Service)(Farnan, Michael) (Entered: 01/13/2026)
2026-01-13
1
REQUEST for Oral Argument by 10X Genomics, Inc., Prognosys Biosciences, Inc. re 255 MOTION for Partial Summary Judgment . (Ewing, Alexandra) (Entered: 01/14/2026)
2026-01-14
1
REQUEST for Oral Argument by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc. re 255 MOTION for Partial Summary Judgment . (Farnan, Brian) (Entered: 01/14/2026)
2026-01-14
1
REDACTED VERSION of 265 Answering Brief in Opposition by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) Modified on 1/16/2026 (dlw). (Entered: 01/15/2026)
2026-01-15
1
REDACTED VERSION of 266 Statement by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) Modified on 1/16/2026 (dlw). (Entered: 01/15/2026)
2026-01-15
1
REDACTED VERSION of 267 Statement by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) Modified on 1/16/2026 (dlw). (Entered: 01/15/2026)
2026-01-15
1
REDACTED VERSION of 268 Declaration by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12)(Monasterio, Gabriela) Modified on 1/16/2026 (dlw). (Entered: 01/15/2026)
2026-01-15
1
REDACTED VERSION of 269 Declaration by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Monasterio, Gabriela) Modified on 1/16/2026 (dlw). (Entered: 01/15/2026)
2026-01-15
1
REDACTED VERSION of 270 Declaration by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Attachments: # 1 Exhibit A)(Monasterio, Gabriela) Modified on 1/16/2026 (dlw). (Entered: 01/15/2026)
2026-01-15
1
STIPULATION TO EXTEND TIME Fact Discovery to January 21, 2026 - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Ewing, Alexandra) (Entered: 01/16/2026)
2026-01-16
1
SO ORDERED re 282 STIPULATION and Order to Extend Close of Fact Discovery. Signed by Judge Maryellen Noreika on 1/16/2026. (dlw) (Entered: 01/16/2026)
2026-01-16
1
REDACTED VERSION of 271 Reply Brief by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Farnan, Michael) (Entered: 01/20/2026)
2026-01-20
1
REDACTED VERSION of 272 Statement, by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Farnan, Michael) (Entered: 01/20/2026)
2026-01-20
1
REDACTED VERSION of 273 Declaration, by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Exhibits Q-U)(Farnan, Michael) (Entered: 01/20/2026)
2026-01-20
1
NOTICE OF SERVICE of Plaintiffs' Third Supplemental Responses and Objections to Defendant's Fifth Set of Interrogatories filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Monasterio, Gabriela) Modified on 1/21/2026 (dlw). (Entered: 01/21/2026)
2026-01-21
1
NOTICE OF SERVICE of Defendants' Third Amended Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc..(Farnan, Brian) (Entered: 01/23/2026)
2026-01-23
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takara Bio USA Holdings, Inc. for Curio Bioscience, Inc., Takara Bio USA, Inc.; Corporate Parent Takara Bio Inc. for Takara Bio USA Holdings, Inc. filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Farnan, Brian) (Entered: 01/23/2026)
2026-01-23
1
[SEALED] DECLARATION of Ian M. Hurst re 256 Opening Brief in Support, by Curio Bioscience, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Certificate of Service)(Farnan, Brian) (Entered: 02/02/2026)
2026-02-02
1
REDACTED VERSION of 256 (Corrected Version) Opening Brief in Support by Curio Bioscience, Inc. (Farnan, Brian) Modified on 2/10/2026 (dlw). (Entered: 02/09/2026)
2026-02-09
1
REDACTED VERSION of 257 (Corrected Version) Statement by Curio Bioscience, Inc. (Farnan, Brian) Modified on 2/10/2026 (dlw). (Entered: 02/09/2026)
2026-02-09
1
REDACTED VERSION of 290 Declaration, by Curio Bioscience, Inc.. (Farnan, Brian) (Entered: 02/09/2026)
2026-02-09
1
MOTION for Pro Hac Vice Appearance of Attorney Azra M. Hadzimehmedovic - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 Affidavit)(Ewing, Alexandra) (Entered: 03/02/2026)
2026-03-02
1
Pro Hac Vice Fee - Credit Card Payment received for Azra M. Hadzimehmedovic. ( re 294 MOTION for Pro Hac Vice Appearance of Attorney Azra M. Hadzimehmedovic )( Payment of $ 50, receipt number ADEDC-4912165).(Ewing, Alexandra) (Entered: 03/02/2026)
2026-03-02
1
SO ORDERED
2026-03-02
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2026-03-02
1
No Actions
SO ORDERED re 294 MOTION for Pro Hac Vice Appearance of Attorney Azra M. Hadzimehmedovic filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. ORDERED by Judge Maryellen Noreika on 3/2/2026. (dlw)
2026-03-02
1
No Actions
Add Attorneys - PHV only
2026-03-03
1
No Actions
Pro Hac Vice Attorney Azra Hadzimehmedovic for 10X Genomics, Inc. & Prognosys Biosciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk)
2026-03-03
1
No Actions
NOTICE requesting Clerk to remove Parshad K. Brahmbhatt as co-counsel. Reason for request: no longer associated with the firm of Tensegrity Law Group LLP. (Monasterio, Gabriela) (Entered: 03/10/2026)
2026-03-10
1
STIPULATION and [Proposed] Order Regarding Pretrial Schedule - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Monasterio, Gabriela) (Entered: 03/11/2026)
2026-03-11
1
SO ORDERED re 297 STIPULATION and Order Regarding Pretrial Schedule. ORDERED by Judge Maryellen Noreika on 3/11/2026. (dlw) (Entered: 03/11/2026)
2026-03-11
1
MOTION for Clarification of Claim Construction - filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Text of Proposed Order, # 2 7.1.1 Certification)(Farnan, Michael) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] OPENING BRIEF in Support re 299 MOTION for Clarification of Claim Construction filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc..Answering Brief/Response due date per Local Rules is 3/27/2026. (Attachments: # 1 Certificate of Service)(Farnan, Michael) (Entered: 03/13/2026)
2026-03-13
1
[SEALED] DECLARATION of Ian M. Hurst in Support of Defendants' Motion for Clarification of Claim Construction re 300 Opening Brief in Support, by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Certificate of Service)(Farnan, Michael) (Entered: 03/13/2026)
2026-03-13
1
~Util - Set Deadlines/Hearings
2026-03-16
1
No Actions
ORAL ORDER - By emailed dated 3/16/2026, the parties contacted Chambers to request a discovery dispute hearing date regarding expert discovery disputes, IT IS HEREBY ORDERED that an in-person Discovery Dispute Hearing is set for 3/23/2026 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. The Court is setting aside thirty (30) minutes for the hearing with the time split equally between the parties. No written submissions will be accepted prior to the hearing. ORDERED by Judge Maryellen Noreika on 3/16/2026. (dlw)
2026-03-16
1
No Actions
NOTICE to Take Deposition of Alan Heinrich on March 25, 2026, 9:00 am PT filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 03/19/2026)
2026-03-19
1
REDACTED VERSION of 300 Opening Brief in Support, by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Farnan, Michael) (Entered: 03/20/2026)
2026-03-20
1
REDACTED VERSION of 301 Declaration,, by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Exhibits A-L)(Farnan, Michael) (Entered: 03/20/2026)
2026-03-20
1
Discovery Conference
2026-03-23
1
No Actions
Minute Entry for proceedings held before Judge Maryellen Noreika - Discovery Conference held on 3/23/2026. The defendant raised two discovery disputes. The parties came to a resolution on defendant's first issue, and on defendant's second issue regarding request for an additional 7-hours to re-depose one of the plaintiffs' experts, the court will take a closer look and issue an order in due course. (Court Reporter Dale Hawkins.) (mdb)
2026-03-23
1
No Actions
NOTICE OF SERVICE of Defendants' Supplemental Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 18-25) filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc..(Farnan, Brian) (Entered: 03/24/2026)
2026-03-24
1
MOTION for Pro Hac Vice Appearance of Attorney Yiye Fu - filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Farnan, Brian) (Entered: 03/25/2026)
2026-03-25
1
Pro Hac Vice Fee - Credit Card Payment received for Yiye Fu. ( re 306 MOTION for Pro Hac Vice Appearance of Attorney Yiye Fu )( Payment of $ 50, receipt number ADEDC-4931886).(Farnan, Brian) (Entered: 03/25/2026)
2026-03-25
1
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2026-03-25
1
No Actions
SO ORDERED re 306 MOTION for Pro Hac Vice Appearance of Attorney Yiye Fu filed by Takara Bio USA, Inc., Curio Bioscience, Inc., Takara Bio USA Holdings, Inc. ORDERED by Judge Maryellen Noreika on 3/25/2026. (dlw)
2026-03-25
1
No Actions
SO ORDERED
2026-03-25
1
No Actions
[SEALED] ANSWERING BRIEF in Opposition re 299 MOTION for Clarification of Claim Construction filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. Reply Brief due date per Local Rules is 4/6/2026. (Rawnsley, Jason) Modified on 3/30/2026 (dlw). (Entered: 03/27/2026)
2026-03-27
1
[SEALED] DECLARATION of Kiley White re 308 Answering Brief in Opposition, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1-9)(Rawnsley, Jason) (Entered: 03/27/2026)
2026-03-27
1
Add Attorneys - PHV only
2026-03-30
1
No Actions
Pro Hac Vice Attorney Yiye Fu for Curio Bioscience, Inc., Takara Bio USA, Inc. & Takara Bio USA Holdings, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (slk)
2026-03-30
1
No Actions
Official Transcript of Discovery Conference held on 03/23/2026 before Judge Maryellen Noreika. Court Reporter/Transcriber Dale C. Hawkins,Email: Dale_Hawkins@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 4/21/2026. Redacted Transcript Deadline set for 5/1/2026. Release of Transcript Restriction set for 6/29/2026. (dh) (Entered: 03/31/2026)
2026-03-31
1
ORAL ORDER - IT IS HEREBY ORDERED that, in consideration of the arguments raised at the discovery conference held on 03/23/2026, Defendant is allowed an additional two (2) hours to depose Dr. Satija (Plaintiff's expert on invalidity issues). ORDERED by Judge Maryellen Noreika on 4/1/2026. (dlw) (Entered: 04/01/2026)
2026-04-01
1
Oral Order
2026-04-01
1
No Actions
NOTICE OF SERVICE of Defendants' Second Supplemental Objections and Responses to Plaintiffs' Third Set of Interrogatories (Nos. 18-25) filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc..(Farnan, Brian) (Entered: 04/02/2026)
2026-04-02
1
REDACTED VERSION of 308 Answering Brief in Opposition, by 10X Genomics, Inc.. (Monasterio, Gabriela) (Entered: 04/03/2026)
2026-04-03
1
REDACTED VERSION of 309 Declaration by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1-9)(Monasterio, Gabriela) (Entered: 04/03/2026)
2026-04-03
1
NOTICE requesting Clerk to remove Natasha Saputo, Joanna Schacter as co-counsel. Reason for request: no longer associated with the firm of Tensegrity Law Group LLP. (Monasterio, Gabriela) (Entered: 04/03/2026)
2026-04-03
1
[SEALED] REPLY BRIEF re 299 MOTION for Clarification of Claim Construction filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 04/06/2026)
2026-04-06
1
[SEALED] DECLARATION of Ian M. Hurst re 316 Reply Brief, by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Exhibit M, # 2 Exhibit N, # 3 Certificate of Service)(Farnan, Brian) (Entered: 04/06/2026)
2026-04-06
1
MOTION for Pro Hac Vice Appearance of Attorney John C. Pierce - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Monasterio, Gabriela) (Entered: 04/08/2026)
2026-04-08
1
Pro Hac Vice Fee - Credit Card Payment received for John C. Pierce. ( re 318 MOTION for Pro Hac Vice Appearance of Attorney John C. Pierce )( Payment of $ 50, receipt number ADEDC-4941592).(Monasterio, Gabriela) (Entered: 04/08/2026)
2026-04-08
1
SO ORDERED
2026-04-08
1
No Actions
-District Court Pro Hac Vice Fee - 01 Attorney Credit Card Payment
2026-04-08
1
No Actions
SO ORDERED re 318 MOTION for Pro Hac Vice Appearance of Attorney John C. Pierce filed by 10X Genomics, Inc., Prognosys Biosciences, Inc. ORDERED by Judge Maryellen Noreika on 4/8/2026. (dlw)
2026-04-08
1
No Actions
STIPULATION Regarding Precluding Certain Evidence and Argument at Trial - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Monasterio, Gabriela) (Entered: 04/09/2026)
2026-04-09
1
REQUEST for Oral Argument by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc. re 299 MOTION for Clarification of Claim Construction . (Farnan, Michael) (Entered: 04/09/2026)
2026-04-09
1
SO ORDERED re 320 STIPULATION and Order Regarding Precluding Certain Evidence and Argument at Trial. Signed by Judge Maryellen Noreika on 4/9/2026. (dlw) (Entered: 04/09/2026)
2026-04-09
1
Pro Hac Vice Attorney John C. Pierce for 10X Genomics, Inc., and Prognosys Biosciences, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam)
2026-04-09
1
No Actions
Add Attorneys - PHV only
2026-04-09
1
No Actions
NOTICE OF SERVICE of (1) Plaintiffs 10x Genomics, Inc. and Prognosys Biosciences, Inc.'s Fourth Supplemental Objections and Responses to Curio Bioscience, Inc.'s Fifth Set of Interrogatories (Nos. 10-18) and (2) 10x's Disclosure of Expert Compensation filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Ewing, Alexandra) (Entered: 04/10/2026)
2026-04-10
1
REDACTED VERSION of 316 Reply Brief, by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Farnan, Michael) (Entered: 04/13/2026)
2026-04-13
1
REDACTED VERSION of 317 Declaration, by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc.. (Attachments: # 1 Exhibits M-N)(Farnan, Michael) (Entered: 04/13/2026)
2026-04-13
1
NOTICE to Take Deposition of William Bill Christiansen on April 22, 2026, 4:00 PM EST filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Monasterio, Gabriela) (Entered: 04/13/2026)
2026-04-13
1
ORDER DENYING 299 MOTION for Clarification of Claim Construction. Signed by Judge Maryellen Noreika on 4/15/2026. (dlw) (Entered: 04/15/2026)
2026-04-15
1
NOTICE OF SERVICE of Defendants' Notice Pursuant to 35 U.S.C. § 282 filed by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc..(Farnan, Brian) (Entered: 04/24/2026)
2026-04-24
1
[SEALED] Proposed Pretrial Order by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Ewing, Alexandra) (Entered: 04/24/2026)
2026-04-24
1
NOTICE of Change of Name (for pro hac vice attorney) by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc. (Farnan, Brian) Modified on 4/29/2026 (dlw). (Entered: 04/29/2026)
2026-04-29
1
NOTICE OF SERVICE of Supplemental Expert Report and Disclosure of Julie L. Davis filed by 10X Genomics, Inc., Prognosys Biosciences, Inc..(Rawnsley, Jason) (Entered: 04/29/2026)
2026-04-29
1
Proposed VERDICT SHEET by Curio Bioscience, Inc., Takara Bio USA, Inc., Takara Bio USA Holdings, Inc. (Farnan, Brian) Modified on 5/1/2026 (mdb). (Entered: 05/01/2026)
2026-05-01
1
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
1
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
REDACTED VERSION of 329 Proposed Pretrial Order, by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9a, # 10 Exhibit 9b, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19)(Monasterio, Gabriela) (Entered: 05/01/2026)
2026-05-01
2
Proposed Voir Dire by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 05/01/2026)
2026-05-01
1
Proposed PRELIMINARY Jury Instructions by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Rawnsley, Jason) Modified on 5/4/2026 (dlw). (Entered: 05/01/2026)
2026-05-01
1
PROPOSED VERDICT SHEET by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Rawnsley, Jason) Modified on 5/4/2026 (dlw). (Entered: 05/01/2026)
2026-05-01
1
Proposed FINAL Jury Instructions by 10X Genomics, Inc., Prognosys Biosciences, Inc. . (Rawnsley, Jason) Modified on 5/4/2026 (dlw). (Entered: 05/01/2026)
2026-05-01
1
STIPULATION and [Proposed] Order Staying Case - filed by 10X Genomics, Inc., Prognosys Biosciences, Inc.. (Rawnsley, Jason) (Entered: 05/08/2026)
2026-05-08
1
SO ORDERED re 338 STIPULATION and Order Staying Case - IT IS HEREBY ORDERED that the Stipulation is GRANTED. If a dismissal is not filed by 6/8/2026, the parties shall file a joint status report on that date. Scheduling Order deadlines TERMIANTED. ORDERED by Judge Maryellen Noreika on 5/8/2026. (dlw)
2026-05-08
1
No Actions
1 - Terminate Deadlines and Hearings AND 1 - Terminate Scheduling Order Deadlines AND SO ORDERED
2026-05-08
1
No Actions
Joint STATUS REPORT of June 8, 2026 by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Rawnsley, Jason) Modified on 6/8/2026 (dlw). (Entered: 06/08/2026)
2026-06-08
1
ORAL ORDER re 339 Joint Status Report - IT IS HEREBY ORDERED that if a dismissal is not filed by 6/22/2026, the parties shall file a further joint status report on that date. ORDERED by Judge Maryellen Noreika on 6/8/2026. (dlw) (Entered: 06/08/2026)
2026-06-08
1
Oral Order
2026-06-08
1
No Actions
STIPULATION of Dismissal with prejudice by 10X Genomics, Inc., Prognosys Biosciences, Inc. (Rawnsley, Jason) Modified on 6/22/2026 (dlw). (Entered: 06/18/2026)
2026-06-18
1
SO ORDERED re 341 Stipulation of Dismissal (with prejudice) ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 6/22/2026. (dlw) (Entered: 06/22/2026)
2026-06-22
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Stipulation of Dismissal)(mdb) (Entered: 06/22/2026)
2026-06-22
1